AATK	1	
ABCB1	6	1_KEGG_ABC_TRANSPORTERS	0.333	2_RESPONSE_TO_DRUG	0.333	
ABCE1	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	
ABL1	3	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CHROMOSOME	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_DNA_REPAIR	1.000	
ABL2	3	2_TRANSMEMBRANE_RECEPTOR_PROTEIN_PHOSPHATASE_ACTIVITY	0.667	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	1_KEGG_ERBB_SIGNALING_PATHWAY	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	0.333	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.333	
ACAN	7	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	0.714	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.143	0_HALLMARK_G2M_CHECKPOINT	0.143	0_HALLMARK_E2F_TARGETS	0.143	0_HALLMARK_MYC_TARGETS_V1	0.143	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.143	1_KEGG_DNA_REPLICATION	0.143	1_KEGG_MISMATCH_REPAIR	0.143	1_KEGG_CELL_CYCLE	0.143	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	0.143	
ACLY	2	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	2_NUCLEUS	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_BIOPOLYMER_METABOLIC_PROCESS	1.000	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1.000	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	1.000	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	1.000	
ACTA1	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_COLORECTAL_CANCER	0.667	1_KEGG_ENDOMETRIAL_CANCER	0.667	1_KEGG_GLIOMA	0.667	1_KEGG_PROSTATE_CANCER	0.667	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	0.667	0_HALLMARK_HYPOXIA	0.333	0_HALLMARK_G2M_CHECKPOINT	0.333	
ACTG1	2	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_MAPK_SIGNALING_PATHWAY	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	
ACTR1B	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_THYROID_CANCER	1.000	2_NUCLEOPLASM	1.000	2_ORGANELLE_PART	1.000	
ADAM12	1	
ADAM17	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_APOPTOSIS	1.000	
ADAMTS10	1	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	1.000	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	1.000	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
ADAMTS14	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_COMPLEMENT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	1.000	
ADAMTS17	1	
ADAMTS19	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	
ADAMTS6	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	2_NUCLEOPLASM	1.000	2_ORGANELLE_PART	1.000	2_NUCLEAR_CHROMOSOME	1.000	
ADAMTS7	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	1.000	2_NUCLEAR_PART	1.000	2_ORGANELLE_LUMEN	1.000	2_NUCLEAR_LUMEN	1.000	
ADCY1	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_BASE_EXCISION_REPAIR	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_APOPTOSIS	0.500	
ADCY2	3	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_WNT_SIGNALING_PATHWAY	0.667	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	0.667	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	0.667	1_KEGG_PROSTATE_CANCER	0.667	
ADCY3	2	1_KEGG_OOCYTE_MEIOSIS	1.000	1_KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	1.000	1_KEGG_GAP_JUNCTION	1.000	1_KEGG_GNRH_SIGNALING_PATHWAY	1.000	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	1.000	1_KEGG_MELANOGENESIS	1.000	1_KEGG_VIBRIO_CHOLERAE_INFECTION	1.000	1_KEGG_DILATED_CARDIOMYOPATHY	1.000	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.500	1_KEGG_CHEMOKINE_SIGNALING_PATHWAY	0.500	
ADCY5	1	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_GNRH_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	1_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	1.000	1_KEGG_DILATED_CARDIOMYOPATHY	1.000	
ADCY7	2	1_KEGG_CHEMOKINE_SIGNALING_PATHWAY	1.000	1_KEGG_GAP_JUNCTION	1.000	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	1.000	1_KEGG_DILATED_CARDIOMYOPATHY	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_PURINE_METABOLISM	0.500	1_KEGG_MAPK_SIGNALING_PATHWAY	0.500	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.500	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	0.500	
ADD1	3	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	0.333	2_NEGATIVE_REGULATION_OF_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.333	2_NEGATIVE_REGULATION_OF_DNA_BINDING	0.333	2_NEGATIVE_REGULATION_OF_TRANSCRIPTION	0.333	2_NEGATIVE_REGULATION_OF_BINDING	0.333	2_NEGATIVE_REGULATION_OF_TRANSCRIPTION_FACTOR_ACTIVITY	0.333	2_TRANSCRIPTION_REPRESSOR_ACTIVITY	0.333	
ADRBK1	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	
AGAP2	1	
AKAP11	1	
AKAP9	2	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_BASE_EXCISION_REPAIR	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_APOPTOSIS	0.500	
AKT1	7	1_KEGG_PATHWAYS_IN_CANCER	0.857	1_KEGG_COLORECTAL_CANCER	0.857	0_HALLMARK_E2F_TARGETS	0.714	1_KEGG_CELL_CYCLE	0.714	1_KEGG_FOCAL_ADHESION	0.714	1_KEGG_PROSTATE_CANCER	0.714	2_DNA_METABOLIC_PROCESS	0.714	2_DNA_REPLICATION	0.714	0_HALLMARK_G2M_CHECKPOINT	0.571	1_KEGG_DNA_REPLICATION	0.571	
AKT3	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	1.000	0_HALLMARK_APOPTOSIS	0.667	0_HALLMARK_UV_RESPONSE_DN	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_COLORECTAL_CANCER	0.667	1_KEGG_ENDOMETRIAL_CANCER	0.667	
ALK	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_MYOGENESIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	
AMH	2	
AMPH	3	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	2_ORGANELLE_PART	1.000	2_NUCLEAR_PART	1.000	2_ORGANELLE_LUMEN	1.000	2_NUCLEAR_LUMEN	1.000	
ANAPC7	3	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_MYC_TARGETS_V1	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_COLORECTAL_CANCER	0.667	
ANK1	1	
ANK2	9	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_GLIOMA	0.556	1_KEGG_FOCAL_ADHESION	0.444	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.444	1_KEGG_COLORECTAL_CANCER	0.444	1_KEGG_PROSTATE_CANCER	0.444	1_KEGG_SMALL_CELL_LUNG_CANCER	0.444	2_NUCLEUS	0.444	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.444	2_DNA_REPLICATION	0.444	
ANK3	16	1_KEGG_PATHWAYS_IN_CANCER	0.688	1_KEGG_CELL_CYCLE	0.563	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_PROSTATE_CANCER	0.500	2_NUCLEUS	0.500	0_HALLMARK_G2M_CHECKPOINT	0.438	1_KEGG_COLORECTAL_CANCER	0.438	2_NON_MEMBRANE_BOUND_ORGANELLE	0.438	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.438	2_CHROMOSOME	0.438	
ANTXR1	1	
ANXA11	1	
AP2A1	2	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ALLOGRAFT_REJECTION	0.500	1_KEGG_PYRIMIDINE_METABOLISM	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_BASE_EXCISION_REPAIR	0.500	
APAF1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_NON_HOMOLOGOUS_END_JOINING	1.000	1_KEGG_CELL_CYCLE	1.000	
APBA1	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_COLORECTAL_CANCER	0.500	2_NUCLEUS	0.500	
APBA2	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_IL2_STAT5_SIGNALING	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_APOPTOSIS	0.500	1_KEGG_WNT_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.500	
APC	147	1_KEGG_PATHWAYS_IN_CANCER	0.857	1_KEGG_COLORECTAL_CANCER	0.735	1_KEGG_CELL_CYCLE	0.667	1_KEGG_ENDOMETRIAL_CANCER	0.660	1_KEGG_PROSTATE_CANCER	0.646	2_NUCLEUS	0.633	0_HALLMARK_E2F_TARGETS	0.585	1_KEGG_P53_SIGNALING_PATHWAY	0.565	2_CELL_PROLIFERATION_GO_0008283	0.565	1_KEGG_SMALL_CELL_LUNG_CANCER	0.524	
APEX1	1	1_KEGG_BASE_EXCISION_REPAIR	1.000	2_BASE_EXCISION_REPAIR	1.000	2_HYDROLASE_ACTIVITY_ACTING_ON_GLYCOSYL_BONDS	1.000	2_LYASE_ACTIVITY	1.000	2_HYDROLASE_ACTIVITY_HYDROLYZING_N_GLYCOSYL_COMPOUNDS	1.000	2_CARBON_OXYGEN_LYASE_ACTIVITY	1.000	2_ENDONUCLEASE_ACTIVITY	1.000	2_NUCLEASE_ACTIVITY	1.000	
APOA1	1	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
APOB	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.250	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	0.250	1_KEGG_MAPK_SIGNALING_PATHWAY	0.250	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	0.250	1_KEGG_APOPTOSIS	0.250	1_KEGG_FOCAL_ADHESION	0.250	1_KEGG_ECM_RECEPTOR_INTERACTION	0.250	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	0.250	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.250	1_KEGG_PATHWAYS_IN_CANCER	0.250	
APP	5	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_CELL_CYCLE	0.800	1_KEGG_FOCAL_ADHESION	0.800	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	1_KEGG_PROSTATE_CANCER	0.800	2_ORGANELLE_PART	0.800	2_NUCLEAR_PART	0.800	2_ORGANELLE_LUMEN	0.800	2_NUCLEAR_LUMEN	0.800	2_NUCLEUS	0.800	
AR	25	1_KEGG_PATHWAYS_IN_CANCER	0.960	1_KEGG_CELL_CYCLE	0.840	2_NUCLEUS	0.800	1_KEGG_PROSTATE_CANCER	0.760	0_HALLMARK_E2F_TARGETS	0.720	1_KEGG_COLORECTAL_CANCER	0.720	2_BIOPOLYMER_METABOLIC_PROCESS	0.680	2_CELL_PROLIFERATION_GO_0008283	0.680	1_KEGG_P53_SIGNALING_PATHWAY	0.640	1_KEGG_FOCAL_ADHESION	0.640	
ARAP1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	2_NUCLEUS	1.000	
ARHGAP5	1	
ARHGEF6	2	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_MAPK_SIGNALING_PATHWAY	0.500	1_KEGG_CELL_CYCLE	0.500	
ARID1A	13	1_KEGG_PATHWAYS_IN_CANCER	0.846	2_NUCLEUS	0.769	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.769	0_HALLMARK_E2F_TARGETS	0.692	1_KEGG_CELL_CYCLE	0.692	1_KEGG_COLORECTAL_CANCER	0.692	2_DNA_METABOLIC_PROCESS	0.692	0_HALLMARK_G2M_CHECKPOINT	0.615	0_HALLMARK_MYC_TARGETS_V1	0.615	1_KEGG_DNA_REPLICATION	0.615	
ARID4B	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
ARMC6	1	
ARNTL2	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_MTORC1_SIGNALING	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_CIRCADIAN_RHYTHM_MAMMAL	1.000	
ATF1	1	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_MELANOMA	1.000	
ATM	23	2_DNA_METABOLIC_PROCESS	0.913	1_KEGG_CELL_CYCLE	0.870	1_KEGG_PATHWAYS_IN_CANCER	0.870	2_NUCLEUS	0.826	0_HALLMARK_G2M_CHECKPOINT	0.783	0_HALLMARK_E2F_TARGETS	0.783	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.739	2_DNA_REPLICATION	0.739	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	0.739	2_CHROMOSOME	0.696	
ATN1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	
ATP2A2	1	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	
ATP2A3	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	
ATR	9	1_KEGG_PATHWAYS_IN_CANCER	0.778	2_DNA_METABOLIC_PROCESS	0.778	1_KEGG_CELL_CYCLE	0.667	2_NUCLEAR_PART	0.667	2_NUCLEUS	0.667	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	0.667	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	0.667	0_HALLMARK_G2M_CHECKPOINT	0.556	0_HALLMARK_E2F_TARGETS	0.556	1_KEGG_DNA_REPLICATION	0.556	
ATRX	4	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_NUCLEUS	1.000	2_CHROMOSOME	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1.000	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	1.000	0_HALLMARK_MYC_TARGETS_V1	0.750	
ATXN1	15	1_KEGG_PATHWAYS_IN_CANCER	0.600	0_HALLMARK_G2M_CHECKPOINT	0.467	0_HALLMARK_E2F_TARGETS	0.467	1_KEGG_COLORECTAL_CANCER	0.467	1_KEGG_ENDOMETRIAL_CANCER	0.467	1_KEGG_PROSTATE_CANCER	0.467	2_NUCLEUS	0.467	0_HALLMARK_MYC_TARGETS_V1	0.400	1_KEGG_CELL_CYCLE	0.400	1_KEGG_FOCAL_ADHESION	0.400	
AXIN1	2	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	
BAX	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
BCAR3	1	
BCL2L11	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	
BCL2L14	1	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	1.000	2_MITOCHONDRIAL_TRANSPORT	1.000	2_REGULATION_OF_MEMBRANE_POTENTIAL	1.000	
BCL6	2	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	1.000	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	1.000	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_MYC_TARGETS_V2	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_PYRIMIDINE_METABOLISM	0.500	
BCLAF1	5	0_HALLMARK_MYC_TARGETS_V1	0.400	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.400	1_KEGG_WNT_SIGNALING_PATHWAY	0.400	1_KEGG_PATHWAYS_IN_CANCER	0.400	2_NUCLEUS	0.400	2_SIGNAL_TRANSDUCTION	0.400	2_TRANSCRIPTION	0.400	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.200	0_HALLMARK_G2M_CHECKPOINT	0.200	0_HALLMARK_MTORC1_SIGNALING	0.200	
BCR	1	0_HALLMARK_MITOTIC_SPINDLE	1.000	2_GTPASE_REGULATOR_ACTIVITY	1.000	2_ENZYME_ACTIVATOR_ACTIVITY	1.000	2_GTPASE_ACTIVATOR_ACTIVITY	1.000	
BDP1	4	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_NUCLEUS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_DNA_REPLICATION	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.750	2_CHROMOSOME	0.750	2_DNA_METABOLIC_PROCESS	0.750	
BGN	2	0_HALLMARK_HYPOXIA	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_P53_PATHWAY	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_NUCLEOLUS	0.500	
BLM	3	1_KEGG_CELL_CYCLE	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_PROSTATE_CANCER	0.667	2_NUCLEUS	0.667	2_SYSTEM_DEVELOPMENT	0.667	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.667	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.667	0_HALLMARK_HYPOXIA	0.333	
BMP15	2	
BMP2	2	1_KEGG_AXON_GUIDANCE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_BASE_EXCISION_REPAIR	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	
BMP3	1	
BMP5	2	
BMP7	2	
BMPR1A	2	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_PROSTATE_CANCER	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_ERBB_SIGNALING_PATHWAY	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	0.500	
BMPR2	6	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	0.667	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	2_DNA_METABOLIC_PROCESS	0.500	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.500	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	0.500	
BOC	1	
BOP1	1	
BRAF	14	0_HALLMARK_E2F_TARGETS	0.643	1_KEGG_FOCAL_ADHESION	0.643	1_KEGG_PATHWAYS_IN_CANCER	0.643	2_DNA_METABOLIC_PROCESS	0.643	1_KEGG_DNA_REPLICATION	0.571	2_BIOPOLYMER_METABOLIC_PROCESS	0.571	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	0.571	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	0.571	0_HALLMARK_G2M_CHECKPOINT	0.500	1_KEGG_CELL_CYCLE	0.500	
BRCA1	7	1_KEGG_CELL_CYCLE	0.857	1_KEGG_PATHWAYS_IN_CANCER	0.857	2_NUCLEUS	0.857	2_DNA_METABOLIC_PROCESS	0.857	0_HALLMARK_G2M_CHECKPOINT	0.714	0_HALLMARK_E2F_TARGETS	0.714	2_NUCLEAR_PART	0.714	2_NON_MEMBRANE_BOUND_ORGANELLE	0.714	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.714	2_CHROMOSOMAL_PART	0.714	
BRCA2	6	0_HALLMARK_E2F_TARGETS	1.000	2_ORGANELLE_PART	1.000	2_NUCLEAR_PART	1.000	2_NUCLEUS	1.000	2_INTRACELLULAR_ORGANELLE_PART	1.000	0_HALLMARK_G2M_CHECKPOINT	0.833	0_HALLMARK_MYC_TARGETS_V1	0.833	1_KEGG_CELL_CYCLE	0.833	1_KEGG_ECM_RECEPTOR_INTERACTION	0.833	1_KEGG_PATHWAYS_IN_CANCER	0.833	
BUB1	2	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	1.000	2_ORGANELLE_PART	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_ORGANELLE_PART	1.000	2_CHROMOSOME	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	0.500	
C1S	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PANCREATIC_CANCER	1.000	
C2	2	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_BIOPOLYMER_METABOLIC_PROCESS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	
C3	3	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	0.333	0_HALLMARK_MTORC1_SIGNALING	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_PROTEASOME	0.333	1_KEGG_BASE_EXCISION_REPAIR	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_FOCAL_ADHESION	0.333	
C5	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	0_HALLMARK_MYC_TARGETS_V1	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	0.667	
C6	1	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	1.000	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	1.000	
CACNA1A	4	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	2_CATION_CHANNEL_ACTIVITY	1.000	2_VOLTAGE_GATED_CHANNEL_ACTIVITY	1.000	2_GATED_CHANNEL_ACTIVITY	1.000	2_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY	1.000	2_VOLTAGE_GATED_CATION_CHANNEL_ACTIVITY	1.000	2_CALCIUM_CHANNEL_ACTIVITY	1.000	1_KEGG_CARDIAC_MUSCLE_CONTRACTION	0.750	1_KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM	0.750	1_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	0.750	
CACNA1B	25	1_KEGG_PATHWAYS_IN_CANCER	0.680	0_HALLMARK_E2F_TARGETS	0.520	1_KEGG_CELL_CYCLE	0.520	0_HALLMARK_G2M_CHECKPOINT	0.480	2_NUCLEUS	0.480	2_DNA_METABOLIC_PROCESS	0.480	2_DNA_REPLICATION	0.480	2_CELL_PROLIFERATION_GO_0008283	0.480	1_KEGG_DNA_REPLICATION	0.440	1_KEGG_PROSTATE_CANCER	0.440	
CACNA1D	3	1_KEGG_MAPK_SIGNALING_PATHWAY	0.333	1_KEGG_CARDIAC_MUSCLE_CONTRACTION	0.333	1_KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM	0.333	1_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	0.333	1_KEGG_DILATED_CARDIOMYOPATHY	0.333	2_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX	0.333	
CACNA1E	8	1_KEGG_MAPK_SIGNALING_PATHWAY	0.500	2_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX	0.375	2_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY	0.375	1_KEGG_DILATED_CARDIOMYOPATHY	0.250	2_CATION_CHANNEL_ACTIVITY	0.250	2_VOLTAGE_GATED_CHANNEL_ACTIVITY	0.250	2_GATED_CHANNEL_ACTIVITY	0.250	2_VOLTAGE_GATED_CATION_CHANNEL_ACTIVITY	0.250	2_CALCIUM_CHANNEL_ACTIVITY	0.250	0_HALLMARK_APOPTOSIS	0.125	
CACNA1F	1	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CARDIAC_MUSCLE_CONTRACTION	1.000	1_KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM	1.000	1_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	1.000	1_KEGG_DILATED_CARDIOMYOPATHY	1.000	2_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX	1.000	
CACNA1H	16	1_KEGG_PATHWAYS_IN_CANCER	0.688	1_KEGG_COLORECTAL_CANCER	0.563	1_KEGG_PROSTATE_CANCER	0.563	1_KEGG_CELL_CYCLE	0.500	1_KEGG_FOCAL_ADHESION	0.500	0_HALLMARK_G2M_CHECKPOINT	0.438	1_KEGG_MAPK_SIGNALING_PATHWAY	0.438	2_NUCLEUS	0.438	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.438	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.438	
CACNA2D2	1	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	
CACNA2D3	2	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM	1.000	1_KEGG_DILATED_CARDIOMYOPATHY	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	0.500	0_HALLMARK_MYC_TARGETS_V2	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_CARDIAC_MUSCLE_CONTRACTION	0.500	1_KEGG_WNT_SIGNALING_PATHWAY	0.500	
CACNA2D4	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	
CAD	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_MYC_TARGETS_V1	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_PYRIMIDINE_METABOLISM	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	2_ORGANELLE_PART	0.667	2_NUCLEAR_PART	0.667	
CALD1	3	
CAMK2D	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	
CAMK2G	1	0_HALLMARK_MTORC1_SIGNALING	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_CALCIUM_SIGNALING_PATHWAY	1.000	1_KEGG_OOCYTE_MEIOSIS	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_MELANOGENESIS	1.000	2_NUCLEUS	1.000	2_MACROMOLECULAR_COMPLEX	1.000	2_PROTEIN_COMPLEX	1.000	
CARD11	1	2_IMMUNOLOGICAL_SYNAPSE	1.000	2_REGULATION_OF_DNA_BINDING	1.000	2_POSITIVE_REGULATION_OF_BINDING	1.000	2_ACTIVATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR	1.000	2_REGULATION_OF_TRANSCRIPTION_FACTOR_ACTIVITY	1.000	2_POSITIVE_REGULATION_OF_TRANSCRIPTION_FACTOR_ACTIVITY	1.000	2_POSITIVE_REGULATION_OF_DNA_BINDING	1.000	
CASC5	5	0_HALLMARK_G2M_CHECKPOINT	0.800	1_KEGG_CELL_CYCLE	0.800	2_CHROMOSOMAL_PART	0.800	2_CHROMOSOME	0.800	0_HALLMARK_E2F_TARGETS	0.600	0_HALLMARK_UV_RESPONSE_DN	0.600	2_DNA_METABOLIC_PROCESS	0.600	2_DNA_REPAIR	0.600	2_BIOPOLYMER_METABOLIC_PROCESS	0.600	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	0.600	
CASK	3	1_KEGG_CELL_CYCLE	0.667	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_COLORECTAL_CANCER	0.667	1_KEGG_PROSTATE_CANCER	0.667	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	2_NUCLEUS	0.667	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.667	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	0.667	
CASP2	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_MYOGENESIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	
CASP8	5	0_HALLMARK_G2M_CHECKPOINT	0.600	0_HALLMARK_E2F_TARGETS	0.600	0_HALLMARK_MYC_TARGETS_V1	0.600	1_KEGG_CELL_CYCLE	0.600	1_KEGG_P53_SIGNALING_PATHWAY	0.600	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	1_KEGG_PATHWAYS_IN_CANCER	0.600	2_NUCLEAR_PART	0.600	2_NON_MEMBRANE_BOUND_ORGANELLE	0.600	2_NUCLEUS	0.600	
CASP9	1	
CAV1	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_COLLAGEN	1.000	2_INTEGRIN_COMPLEX	1.000	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	1.000	
CBFA2T3	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
CBL	2	0_HALLMARK_P53_PATHWAY	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	1.000	
CCNA1	4	1_KEGG_CELL_CYCLE	0.500	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_APOPTOSIS	0.250	0_HALLMARK_E2F_TARGETS	0.250	1_KEGG_DNA_REPLICATION	0.250	1_KEGG_MAPK_SIGNALING_PATHWAY	0.250	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	0.250	1_KEGG_AXON_GUIDANCE	0.250	1_KEGG_FOCAL_ADHESION	0.250	1_KEGG_ECM_RECEPTOR_INTERACTION	0.250	
CCNA2	1	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	2_NUCLEAR_REPLICATION_FORK	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_NUCLEUS	1.000	2_REPLICATION_FORK	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CHROMOSOMAL_PART	1.000	
CCNB2	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_ERBB_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	1.000	
CCNB3	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CHROMOSOMAL_PART	1.000	2_CHROMOSOME	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_DNA_REPAIR	1.000	
CCNE1	3	1_KEGG_PATHWAYS_IN_CANCER	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_MAPK_SIGNALING_PATHWAY	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_PROSTATE_CANCER	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	2_NUCLEAR_PART	0.667	
CCNK	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	2_NUCLEUS	1.000	
CCR10	1	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	1.000	1_KEGG_CHEMOKINE_SIGNALING_PATHWAY	1.000	1_KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	1.000	2_BEHAVIOR	1.000	2_LOCOMOTORY_BEHAVIOR	1.000	2_RESPONSE_TO_CHEMICAL_STIMULUS	1.000	2_RESPONSE_TO_EXTERNAL_STIMULUS	1.000	2_G_PROTEIN_COUPLED_RECEPTOR_BINDING	1.000	2_CHEMOKINE_ACTIVITY	1.000	2_CHEMOKINE_RECEPTOR_BINDING	1.000	
CCT4	1	
CD19	1	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	
CD1E	1	2_FATTY_ACID_BIOSYNTHETIC_PROCESS	1.000	2_ICOSANOID_METABOLIC_PROCESS	1.000	
CD22	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_IL2_STAT5_SIGNALING	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_PROTEASOME	0.500	1_KEGG_BASE_EXCISION_REPAIR	0.500	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_CELL_CYCLE	0.500	
CD24	35	1_KEGG_CELL_CYCLE	0.600	1_KEGG_PATHWAYS_IN_CANCER	0.600	0_HALLMARK_E2F_TARGETS	0.514	0_HALLMARK_G2M_CHECKPOINT	0.486	1_KEGG_COLORECTAL_CANCER	0.486	2_NON_MEMBRANE_BOUND_ORGANELLE	0.486	2_NUCLEUS	0.486	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.486	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.486	0_HALLMARK_MYC_TARGETS_V1	0.457	
CD40	2	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	2_NUCLEUS	1.000	2_BIOPOLYMER_METABOLIC_PROCESS	1.000	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	1.000	2_RESPONSE_TO_STRESS	1.000	
CD48	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	
CD82	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_HEDGEHOG_SIGNALING	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	
CD93	1	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	2_PLASMA_MEMBRANE_PART	1.000	2_PLASMA_MEMBRANE	1.000	
CDC14A	2	
CDC16	1	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	1.000	0_HALLMARK_TGF_BETA_SIGNALING	1.000	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	
CDC23	2	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CHROMOSOME	1.000	2_DNA_METABOLIC_PROCESS	1.000	
CDC25C	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
CDC27	2	1_KEGG_MAPK_SIGNALING_PATHWAY	0.500	1_KEGG_ERBB_SIGNALING_PATHWAY	0.500	1_KEGG_APOPTOSIS	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	0.500	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.500	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.500	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	0.500	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	0.500	
CDC42BPA	1	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	
CDC5L	1	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	
CDC6	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PANCREATIC_CANCER	1.000	
CDC7	1	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	2_REPLICATION_FORK	1.000	2_CHROMOSOMAL_PART	1.000	2_CHROMOSOME	1.000	2_DNA_METABOLIC_PROCESS	1.000	
CDH1	1	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	1.000	0_HALLMARK_TGF_BETA_SIGNALING	1.000	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	
CDH13	1	
CDH17	1	
CDH18	1	
CDH2	3	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_COLORECTAL_CANCER	0.667	1_KEGG_PROSTATE_CANCER	0.667	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.667	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_NOTCH_SIGNALING	0.333	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	0.333	0_HALLMARK_E2F_TARGETS	0.333	
CDH23	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_P53_PATHWAY	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_INTEGRIN_COMPLEX	0.500	2_SYSTEM_DEVELOPMENT	0.500	
CDH8	1	
CDH9	3	
CDKN1B	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	2_NUCLEUS	1.000	
CDKN2C	1	
CDON	2	
CELSR1	17	1_KEGG_PATHWAYS_IN_CANCER	0.529	1_KEGG_FOCAL_ADHESION	0.412	1_KEGG_CELL_CYCLE	0.353	0_HALLMARK_G2M_CHECKPOINT	0.294	0_HALLMARK_E2F_TARGETS	0.294	1_KEGG_AXON_GUIDANCE	0.294	1_KEGG_ECM_RECEPTOR_INTERACTION	0.294	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.294	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.294	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.294	
CENPF	2	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_PURINE_METABOLISM	0.500	1_KEGG_PYRIMIDINE_METABOLISM	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_BASE_EXCISION_REPAIR	0.500	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.500	1_KEGG_MISMATCH_REPAIR	0.500	
CENPI	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	1.000	1_KEGG_CHEMOKINE_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	
CFHR4	1	
CFTR	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_CHROMOSOMAL_PART	1.000	2_CHROMOSOME	1.000	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_PROTEASOME	0.667	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.667	
CGN	1	
CHD1	2	
CHD6	1	
CHD7	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
CHEK2	1	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
CHL1	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	2_ORGANELLE_PART	1.000	2_NUCLEAR_PART	1.000	
CHRDL2	1	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	
CHRNA1	1	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	1.000	0_HALLMARK_INFLAMMATORY_RESPONSE	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	1.000	1_KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	1.000	
CHRNG	1	
CHUK	1	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_HEDGEHOG_SIGNALING	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_SYSTEM_DEVELOPMENT	1.000	
CIITA	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	
CISH	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
CLASP1	6	1_KEGG_CELL_CYCLE	1.000	2_CHROMOSOME	1.000	0_HALLMARK_G2M_CHECKPOINT	0.833	0_HALLMARK_E2F_TARGETS	0.833	1_KEGG_DNA_REPLICATION	0.833	1_KEGG_FOCAL_ADHESION	0.833	1_KEGG_PATHWAYS_IN_CANCER	0.833	2_CHROMOSOMAL_PART	0.833	2_DNA_METABOLIC_PROCESS	0.833	2_DNA_REPLICATION	0.833	
CLDN1	1	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_TIGHT_JUNCTION	1.000	2_CELL_JUNCTION	1.000	2_TIGHT_JUNCTION	1.000	2_INTERCELLULAR_JUNCTION	1.000	2_APICAL_JUNCTION_COMPLEX	1.000	2_APICOLATERAL_PLASMA_MEMBRANE	1.000	2_CALCIUM_INDEPENDENT_CELL_CELL_ADHESION	1.000	2_CELL_CELL_ADHESION	1.000	2_IDENTICAL_PROTEIN_BINDING	1.000	
CLDN10	1	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_TIGHT_JUNCTION	1.000	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	1.000	2_CELL_JUNCTION	1.000	2_MEMBRANE_PART	1.000	2_TIGHT_JUNCTION	1.000	2_INTERCELLULAR_JUNCTION	1.000	2_MEMBRANE	1.000	2_APICAL_JUNCTION_COMPLEX	1.000	2_APICOLATERAL_PLASMA_MEMBRANE	1.000	
CLDN5	1	2_TIGHT_JUNCTION	1.000	2_CALCIUM_INDEPENDENT_CELL_CELL_ADHESION	1.000	
CLIP1	2	0_HALLMARK_G2M_CHECKPOINT	1.000	1_KEGG_CELL_CYCLE	1.000	2_ORGANELLE_PART	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_ORGANELLE_PART	1.000	2_MACROMOLECULAR_COMPLEX	1.000	2_CHROMOSOMAL_PART	1.000	2_PROTEIN_COMPLEX	1.000	2_CHROMOSOME	1.000	
CLK1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	1.000	2_NUCLEAR_PART	1.000	2_ORGANELLE_LUMEN	1.000	2_NUCLEAR_LUMEN	1.000	
CLSPN	5	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_DNA_REPLICATION	1.000	1_KEGG_DNA_REPLICATION	0.800	1_KEGG_MISMATCH_REPAIR	0.800	1_KEGG_PROSTATE_CANCER	0.800	
CNGA3	1	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_CHEMOKINE_SIGNALING_PATHWAY	1.000	1_KEGG_OOCYTE_MEIOSIS	1.000	1_KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	1.000	1_KEGG_GAP_JUNCTION	1.000	1_KEGG_GNRH_SIGNALING_PATHWAY	1.000	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	1.000	1_KEGG_MELANOGENESIS	1.000	1_KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION	1.000	1_KEGG_VIBRIO_CHOLERAE_INFECTION	1.000	
CNTN1	1	
CNTN2	6	1_KEGG_PATHWAYS_IN_CANCER	0.833	1_KEGG_CELL_CYCLE	0.667	2_NUCLEUS	0.667	2_SYSTEM_DEVELOPMENT	0.667	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.667	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_FOCAL_ADHESION	0.500	2_NUCLEAR_PART	0.500	
CNTNAP2	7	
CNTNAP4	2	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	1.000	
COL11A1	9	1_KEGG_PATHWAYS_IN_CANCER	0.778	1_KEGG_SMALL_CELL_LUNG_CANCER	0.778	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PROSTATE_CANCER	0.667	2_NUCLEOLUS	0.667	0_HALLMARK_G2M_CHECKPOINT	0.556	
COL12A1	2	1_KEGG_CELL_CYCLE	1.000	2_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	1.000	2_REGULATION_OF_METABOLIC_PROCESS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_MYC_TARGETS_V2	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_IL2_STAT5_SIGNALING	0.500	1_KEGG_PURINE_METABOLISM	0.500	
COL14A1	11	1_KEGG_PATHWAYS_IN_CANCER	1.000	0_HALLMARK_G2M_CHECKPOINT	0.727	1_KEGG_CELL_CYCLE	0.727	1_KEGG_PROSTATE_CANCER	0.727	0_HALLMARK_E2F_TARGETS	0.636	1_KEGG_FOCAL_ADHESION	0.636	1_KEGG_COLORECTAL_CANCER	0.636	2_NUCLEUS	0.636	1_KEGG_ENDOMETRIAL_CANCER	0.545	1_KEGG_SMALL_CELL_LUNG_CANCER	0.545	
COL15A1	1	
COL18A1	10	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	0.900	1_KEGG_FOCAL_ADHESION	0.800	1_KEGG_COLORECTAL_CANCER	0.800	1_KEGG_PROSTATE_CANCER	0.800	1_KEGG_ECM_RECEPTOR_INTERACTION	0.700	1_KEGG_P53_SIGNALING_PATHWAY	0.600	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.600	2_CELL_PROLIFERATION_GO_0008283	0.600	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	
COL19A1	2	1_KEGG_CELL_CYCLE	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_PROSTATE_CANCER	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	
COL1A1	1	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_NUCLEUS	1.000	2_SYSTEM_DEVELOPMENT	1.000	
COL1A2	5	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_E2F_TARGETS	0.800	1_KEGG_DNA_REPLICATION	0.800	1_KEGG_CELL_CYCLE	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.800	2_NON_MEMBRANE_BOUND_ORGANELLE	0.800	2_NUCLEUS	0.800	2_REPLICATION_FORK	0.800	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.800	2_CHROMOSOMAL_PART	0.800	
COL20A1	2	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	1.000	2_NUCLEUS	1.000	2_INTEGRIN_COMPLEX	1.000	2_BIOPOLYMER_METABOLIC_PROCESS	1.000	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.500	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	0.500	0_HALLMARK_E2F_TARGETS	0.500	
COL22A1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_LATE	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
COL27A1	9	1_KEGG_FOCAL_ADHESION	0.778	1_KEGG_ECM_RECEPTOR_INTERACTION	0.778	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_COLORECTAL_CANCER	0.556	1_KEGG_ENDOMETRIAL_CANCER	0.556	1_KEGG_PROSTATE_CANCER	0.556	1_KEGG_SMALL_CELL_LUNG_CANCER	0.444	1_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	0.444	2_RECEPTOR_COMPLEX	0.444	2_INTEGRIN_COMPLEX	0.444	
COL2A1	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_INTEGRIN_COMPLEX	1.000	
COL3A1	3	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	0.667	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	0.333	0_HALLMARK_MYOGENESIS	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_WNT_SIGNALING_PATHWAY	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	
COL4A1	3	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_MAPK_SIGNALING_PATHWAY	0.667	1_KEGG_APOPTOSIS	0.667	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	0.667	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.667	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.667	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	
COL4A2	5	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_E2F_TARGETS	0.800	0_HALLMARK_MYC_TARGETS_V1	0.800	1_KEGG_FOCAL_ADHESION	0.800	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.800	2_NUCLEUS	0.800	2_NUCLEOLUS	0.800	2_BIOPOLYMER_METABOLIC_PROCESS	0.800	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.600	
COL4A3	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
COL4A5	5	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_FOCAL_ADHESION	0.800	1_KEGG_ENDOMETRIAL_CANCER	0.800	1_KEGG_PROSTATE_CANCER	0.800	0_HALLMARK_G2M_CHECKPOINT	0.600	0_HALLMARK_E2F_TARGETS	0.600	1_KEGG_CELL_CYCLE	0.600	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.600	
COL5A1	6	1_KEGG_PATHWAYS_IN_CANCER	0.833	2_CELL_PROLIFERATION_GO_0008283	0.833	0_HALLMARK_G2M_CHECKPOINT	0.667	1_KEGG_WNT_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.667	1_KEGG_DILATED_CARDIOMYOPATHY	0.667	2_ORGANELLE_LUMEN	0.667	2_NUCLEAR_LUMEN	0.667	
COL5A2	4	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	2_REGULATION_OF_CELL_PROLIFERATION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	
COL5A3	4	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_ORGANELLE_LUMEN	1.000	2_NUCLEAR_LUMEN	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_NUCLEUS	1.000	2_MEMBRANE_ENCLOSED_LUMEN	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_NUCLEOLUS	1.000	
COL6A1	5	1_KEGG_PATHWAYS_IN_CANCER	0.800	0_HALLMARK_DNA_REPAIR	0.600	0_HALLMARK_G2M_CHECKPOINT	0.600	0_HALLMARK_E2F_TARGETS	0.600	0_HALLMARK_MYC_TARGETS_V1	0.600	1_KEGG_DNA_REPLICATION	0.600	1_KEGG_MISMATCH_REPAIR	0.600	1_KEGG_CELL_CYCLE	0.600	1_KEGG_P53_SIGNALING_PATHWAY	0.600	1_KEGG_FOCAL_ADHESION	0.600	
COL6A2	3	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	2_INTEGRIN_COMPLEX	0.667	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.333	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	0.333	0_HALLMARK_ESTROGEN_RESPONSE_LATE	0.333	0_HALLMARK_MYOGENESIS	0.333	0_HALLMARK_P53_PATHWAY	0.333	
COL6A3	18	1_KEGG_FOCAL_ADHESION	0.833	1_KEGG_ECM_RECEPTOR_INTERACTION	0.833	1_KEGG_PATHWAYS_IN_CANCER	0.722	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.722	1_KEGG_CELL_CYCLE	0.611	0_HALLMARK_E2F_TARGETS	0.556	1_KEGG_COLORECTAL_CANCER	0.556	1_KEGG_PROSTATE_CANCER	0.556	2_NUCLEUS	0.556	2_SYSTEM_DEVELOPMENT	0.556	
COL6A6	7	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_CELL_CYCLE	0.857	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.857	1_KEGG_ENDOMETRIAL_CANCER	0.857	0_HALLMARK_G2M_CHECKPOINT	0.714	0_HALLMARK_E2F_TARGETS	0.714	1_KEGG_P53_SIGNALING_PATHWAY	0.714	1_KEGG_GLIOMA	0.714	
COL7A1	2	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_MYC_TARGETS_V2	0.500	0_HALLMARK_IL2_STAT5_SIGNALING	0.500	1_KEGG_PURINE_METABOLISM	0.500	1_KEGG_PYRIMIDINE_METABOLISM	0.500	
CR1	1	
CR2	1	
CREB3	1	1_KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION	1.000	
CREBBP	12	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_CELL_CYCLE	0.917	1_KEGG_PROSTATE_CANCER	0.833	2_NUCLEUS	0.833	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_COLORECTAL_CANCER	0.750	2_BIOPOLYMER_METABOLIC_PROCESS	0.750	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.750	2_CELL_PROLIFERATION_GO_0008283	0.750	0_HALLMARK_G2M_CHECKPOINT	0.667	
CRMP1	4	0_HALLMARK_E2F_TARGETS	1.000	2_NUCLEAR_PART	1.000	2_NUCLEAR_LUMEN	1.000	2_NUCLEUS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_MYC_TARGETS_V1	0.750	1_KEGG_DNA_REPLICATION	0.750	1_KEGG_BASE_EXCISION_REPAIR	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_PATHWAYS_IN_CANCER	0.750	
CRY1	1	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	
CSF2RB	2	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_BIOPOLYMER_METABOLIC_PROCESS	1.000	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1.000	2_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	1.000	2_TRANSCRIPTION	1.000	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	1.000	2_REGULATION_OF_METABOLIC_PROCESS	1.000	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	1.000	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.500	
CSNK1D	1	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_THYROID_CANCER	1.000	
CSNK1G1	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	1_KEGG_DILATED_CARDIOMYOPATHY	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX	1.000	
CSNK2A1	2	1_KEGG_PATHWAYS_IN_CANCER	1.000	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_IL2_STAT5_SIGNALING	0.500	1_KEGG_PURINE_METABOLISM	0.500	1_KEGG_PYRIMIDINE_METABOLISM	0.500	1_KEGG_RNA_POLYMERASE	0.500	
CST7	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	
CTBP1	3	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_APOPTOSIS	0.667	1_KEGG_AXON_GUIDANCE	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.667	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	0.667	
CTBP2	4	1_KEGG_PATHWAYS_IN_CANCER	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_OOCYTE_MEIOSIS	0.500	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	0.500	1_KEGG_COLORECTAL_CANCER	0.500	1_KEGG_ENDOMETRIAL_CANCER	0.500	
CTNNA2	3	
CTNNA3	6	2_CELL_CELL_ADHESION	0.500	1_KEGG_TIGHT_JUNCTION	0.333	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	0.333	2_CELL_JUNCTION	0.333	2_TIGHT_JUNCTION	0.333	2_INTERCELLULAR_JUNCTION	0.333	2_APICAL_JUNCTION_COMPLEX	0.333	2_APICOLATERAL_PLASMA_MEMBRANE	0.333	2_CALCIUM_INDEPENDENT_CELL_CELL_ADHESION	0.333	0_HALLMARK_APICAL_JUNCTION	0.167	
CTNNB1	16	1_KEGG_PATHWAYS_IN_CANCER	0.938	1_KEGG_PROSTATE_CANCER	0.938	1_KEGG_CELL_CYCLE	0.875	1_KEGG_FOCAL_ADHESION	0.875	1_KEGG_COLORECTAL_CANCER	0.813	2_NUCLEUS	0.813	2_DNA_METABOLIC_PROCESS	0.813	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_ENDOMETRIAL_CANCER	0.688	
CTSF	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
CUBN	18	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.056	0_HALLMARK_G2M_CHECKPOINT	0.056	0_HALLMARK_E2F_TARGETS	0.056	0_HALLMARK_MYC_TARGETS_V1	0.056	1_KEGG_PURINE_METABOLISM	0.056	1_KEGG_PYRIMIDINE_METABOLISM	0.056	1_KEGG_DNA_REPLICATION	0.056	1_KEGG_MISMATCH_REPAIR	0.056	1_KEGG_CELL_CYCLE	0.056	1_KEGG_P53_SIGNALING_PATHWAY	0.056	
DAB1	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	
DAZ4	25	
DBF4	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	1.000	
DCC	2	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_LONG_TERM_POTENTIATION	0.500	
DCHS2	1	
DCLK1	4	
DCT	1	
DDR2	2	
DDX20	1	
DGKB	1	1_KEGG_GLYCEROPHOSPHOLIPID_METABOLISM	1.000	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	1.000	
DGKD	1	1_KEGG_GLYCEROPHOSPHOLIPID_METABOLISM	1.000	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	1.000	
DGKG	1	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	1.000	
DGKH	2	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	0.500	
DGKI	1	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	1.000	1_KEGG_CALCIUM_SIGNALING_PATHWAY	1.000	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	1.000	
DHX37	1	
DKC1	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_APOPTOSIS	0.500	1_KEGG_AXON_GUIDANCE	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	0.500	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.500	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	
DLAT	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	2_NUCLEUS	1.000	
DLG4	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_MTORC1_SIGNALING	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_PYRIMIDINE_METABOLISM	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_PROTEASOME	0.500	1_KEGG_BASE_EXCISION_REPAIR	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_CIRCADIAN_RHYTHM_MAMMAL	0.500	
DMD	16	1_KEGG_PATHWAYS_IN_CANCER	0.813	1_KEGG_CELL_CYCLE	0.750	2_NUCLEUS	0.750	0_HALLMARK_E2F_TARGETS	0.688	2_DNA_METABOLIC_PROCESS	0.688	0_HALLMARK_G2M_CHECKPOINT	0.625	1_KEGG_DNA_REPLICATION	0.625	1_KEGG_FOCAL_ADHESION	0.625	1_KEGG_PROSTATE_CANCER	0.625	2_CHROMOSOMAL_PART	0.625	
DNA2	1	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	0_HALLMARK_KRAS_SIGNALING_UP	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_APOPTOSIS	1.000	
DNAJC6	1	
DNM2	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	2_NUCLEAR_PART	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_NUCLEUS	1.000	2_REPLICATION_FORK	1.000	
DOCK1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_COMPLEMENT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	1.000	
DOCK2	1	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	
DOK1	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_SYSTEM_DEVELOPMENT	1.000	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	1.000	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	1.000	2_ORGAN_DEVELOPMENT	1.000	
DOK2	1	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	
DOK5	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_THYROID_CANCER	1.000	
DPYSL5	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	
DRP2	2	
DSP	4	2_CORNIFIED_ENVELOPE	0.750	2_KERATINOCYTE_DIFFERENTIATION	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.250	1_KEGG_APOPTOSIS	0.250	1_KEGG_AXON_GUIDANCE	0.250	1_KEGG_FOCAL_ADHESION	0.250	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.250	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	0.250	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.250	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	0.250	
DTL	1	2_CHROMATIN_REMODELING_COMPLEX	1.000	2_CHROMATIN_ASSEMBLY	1.000	2_NUCLEOSOME_ASSEMBLY	1.000	2_CHROMATIN_BINDING	1.000	
DTNA	3	
DUSP6	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	2_NUCLEOPLASM	1.000	2_ORGANELLE_PART	1.000	2_NUCLEAR_CHROMOSOME	1.000	
DVL3	1	
DZIP1	1	
E2F3	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_SYSTEM_DEVELOPMENT	1.000	2_SIGNAL_TRANSDUCTION	1.000	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	1.000	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	1.000	
E2F4	5	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_NUCLEUS	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_BIOPOLYMER_METABOLIC_PROCESS	1.000	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1.000	2_DNA_REPLICATION	1.000	
E2F6	1	
ECEL1	1	1_KEGG_CALCIUM_SIGNALING_PATHWAY	1.000	1_KEGG_OOCYTE_MEIOSIS	1.000	1_KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	1.000	1_KEGG_GAP_JUNCTION	1.000	1_KEGG_GNRH_SIGNALING_PATHWAY	1.000	1_KEGG_MELANOGENESIS	1.000	1_KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION	1.000	1_KEGG_VIBRIO_CHOLERAE_INFECTION	1.000	
EDNRB	1	2_ANTIPORTER_ACTIVITY	1.000	
EEF1A1	2	
EEF1A2	2	
EEF1D	7	
EFTUD2	1	2_SPLICEOSOME	1.000	
EGF	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_ERBB_SIGNALING_PATHWAY	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	
EGR1	7	1_KEGG_PATHWAYS_IN_CANCER	1.000	0_HALLMARK_G2M_CHECKPOINT	0.714	0_HALLMARK_E2F_TARGETS	0.714	1_KEGG_DNA_REPLICATION	0.714	1_KEGG_MISMATCH_REPAIR	0.714	1_KEGG_CELL_CYCLE	0.714	1_KEGG_FOCAL_ADHESION	0.714	1_KEGG_ECM_RECEPTOR_INTERACTION	0.714	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.714	1_KEGG_SMALL_CELL_LUNG_CANCER	0.714	
EGR2	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	
EIF2AK2	1	0_HALLMARK_APOPTOSIS	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	
EIF3A	1	2_NEURON_APOPTOSIS	1.000	
EIF4G1	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	1.000	
ELMO1	3	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	2_NUCLEOLUS	1.000	2_BIOPOLYMER_METABOLIC_PROCESS	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	
ELN	1	
EP300	8	1_KEGG_PATHWAYS_IN_CANCER	1.000	0_HALLMARK_E2F_TARGETS	0.875	1_KEGG_CELL_CYCLE	0.875	1_KEGG_COLORECTAL_CANCER	0.875	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	0.875	0_HALLMARK_MYC_TARGETS_V1	0.750	1_KEGG_DNA_REPLICATION	0.750	1_KEGG_MISMATCH_REPAIR	0.750	2_NON_MEMBRANE_BOUND_ORGANELLE	0.750	2_NUCLEUS	0.750	
EP400	8	0_HALLMARK_E2F_TARGETS	0.875	1_KEGG_CELL_CYCLE	0.875	1_KEGG_PATHWAYS_IN_CANCER	0.875	1_KEGG_COLORECTAL_CANCER	0.875	0_HALLMARK_G2M_CHECKPOINT	0.750	2_NUCLEUS	0.750	2_CHROMOSOME	0.750	2_DNA_METABOLIC_PROCESS	0.750	2_BIOPOLYMER_METABOLIC_PROCESS	0.750	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.750	
EPAS1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	
EPB41	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
EPB41L3	2	
EPHA3	4	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_MYC_TARGETS_V1	0.750	1_KEGG_DNA_REPLICATION	0.750	1_KEGG_MISMATCH_REPAIR	0.750	
EPHA4	1	
EPHB1	7	1_KEGG_PATHWAYS_IN_CANCER	0.857	0_HALLMARK_E2F_TARGETS	0.714	1_KEGG_CELL_CYCLE	0.714	2_BIOPOLYMER_METABOLIC_PROCESS	0.714	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	0.714	0_HALLMARK_G2M_CHECKPOINT	0.571	1_KEGG_DNA_REPLICATION	0.571	1_KEGG_P53_SIGNALING_PATHWAY	0.571	2_NUCLEAR_PART	0.571	2_ORGANELLE_LUMEN	0.571	
EPOR	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	
EPS8	1	2_MOLECULAR_ADAPTOR_ACTIVITY	1.000	2_SH3_SH2_ADAPTOR_ACTIVITY	1.000	
ERBB2	6	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	0.833	1_KEGG_PROSTATE_CANCER	0.833	2_ORGANELLE_LUMEN	0.833	2_NUCLEAR_LUMEN	0.833	2_MEMBRANE_ENCLOSED_LUMEN	0.833	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	
ERBB3	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_COLORECTAL_CANCER	0.667	1_KEGG_PROSTATE_CANCER	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	2_SYSTEM_DEVELOPMENT	0.667	2_SIGNAL_TRANSDUCTION	0.667	
ERBB4	3	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_PROSTATE_CANCER	1.000	2_ORGANELLE_LUMEN	1.000	2_NUCLEUS	1.000	2_MEMBRANE_ENCLOSED_LUMEN	1.000	
ERCC2	10	2_NUCLEAR_PART	0.600	2_NUCLEAR_LUMEN	0.600	2_NUCLEOLUS	0.600	0_HALLMARK_G2M_CHECKPOINT	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	2_ORGANELLE_LUMEN	0.500	2_NUCLEUS	0.500	2_MEMBRANE_ENCLOSED_LUMEN	0.500	0_HALLMARK_E2F_TARGETS	0.400	
ERCC4	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	1.000	1_KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	1.000	
ERG	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	
ESR1	5	2_SYSTEM_DEVELOPMENT	0.800	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.800	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	0.800	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.600	1_KEGG_PATHWAYS_IN_CANCER	0.600	2_SIGNAL_TRANSDUCTION	0.600	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	0.600	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	0.600	0_HALLMARK_G2M_CHECKPOINT	0.400	0_HALLMARK_E2F_TARGETS	0.400	
ESR2	2	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	2_NUCLEUS	1.000	2_CELL_CYCLE_GO_0007049	1.000	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	
ESRRA	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_MTORC1_SIGNALING	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_CHEMOKINE_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_OOCYTE_MEIOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	
ETS1	1	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_THYROID_CANCER	1.000	
ETV7	1	
F2	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_ERBB_SIGNALING_PATHWAY	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	
FAF1	1	
FANCA	1	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	
FANCD2	2	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_GNRH_SIGNALING_PATHWAY	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	1_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	0.500	1_KEGG_DILATED_CARDIOMYOPATHY	0.500	
FANCE	1	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_NUCLEUS	1.000	2_SYSTEM_DEVELOPMENT	1.000	
FANCL	1	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	1.000	
FANCM	5	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CHROMOSOME	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	1.000	2_DNA_REPLICATION	1.000	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	1.000	
FAS	2	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_MAPK_SIGNALING_PATHWAY	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	
FAT2	10	0_HALLMARK_HYPOXIA	0.100	0_HALLMARK_G2M_CHECKPOINT	0.100	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	0.100	0_HALLMARK_E2F_TARGETS	0.100	0_HALLMARK_MYC_TARGETS_V1	0.100	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.100	0_HALLMARK_UV_RESPONSE_DN	0.100	1_KEGG_DNA_REPLICATION	0.100	1_KEGG_CELL_CYCLE	0.100	1_KEGG_FOCAL_ADHESION	0.100	
FBLN2	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	1.000	
FBN1	16	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_FOCAL_ADHESION	0.438	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.375	1_KEGG_PATHWAYS_IN_CANCER	0.313	2_SYSTEM_DEVELOPMENT	0.313	2_ORGAN_DEVELOPMENT	0.313	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	0.313	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_E2F_TARGETS	0.250	
FBN2	6	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.167	0_HALLMARK_G2M_CHECKPOINT	0.167	0_HALLMARK_E2F_TARGETS	0.167	0_HALLMARK_MYC_TARGETS_V1	0.167	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.167	1_KEGG_DNA_REPLICATION	0.167	1_KEGG_MISMATCH_REPAIR	0.167	1_KEGG_CELL_CYCLE	0.167	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	0.167	1_KEGG_PATHWAYS_IN_CANCER	0.167	
FEV	1	
FEZ1	1	
FGF12	2	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_MYC_TARGETS_V2	0.500	0_HALLMARK_IL2_STAT5_SIGNALING	0.500	1_KEGG_PURINE_METABOLISM	0.500	1_KEGG_PYRIMIDINE_METABOLISM	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_BASE_EXCISION_REPAIR	0.500	
FGF17	1	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_P53_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	
FGFR1	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	2_NUCLEAR_PART	1.000	
FGFR2	2	0_HALLMARK_G2M_CHECKPOINT	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_MELANOMA	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_RESPONSE_TO_STRESS	1.000	0_HALLMARK_HEDGEHOG_SIGNALING	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	
FGFR3	5	1_KEGG_PATHWAYS_IN_CANCER	1.000	0_HALLMARK_E2F_TARGETS	0.800	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	1_KEGG_CELL_CYCLE	0.800	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	2_CHROMOSOME	0.800	2_DNA_METABOLIC_PROCESS	0.800	2_DNA_REPAIR	0.800	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	0.800	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	0.800	
FGFR4	3	1_KEGG_PATHWAYS_IN_CANCER	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_APOPTOSIS	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_MYC_TARGETS_V1	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_APOPTOSIS	0.667	1_KEGG_AXON_GUIDANCE	0.667	
FKBP4	1	
FLNA	3	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_PYRIMIDINE_METABOLISM	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_PROSTATE_CANCER	0.667	2_NUCLEUS	0.667	
FLNC	7	1_KEGG_FOCAL_ADHESION	0.714	1_KEGG_ECM_RECEPTOR_INTERACTION	0.714	1_KEGG_PATHWAYS_IN_CANCER	0.714	1_KEGG_CELL_CYCLE	0.571	1_KEGG_COLORECTAL_CANCER	0.571	1_KEGG_PROSTATE_CANCER	0.571	0_HALLMARK_G2M_CHECKPOINT	0.429	0_HALLMARK_E2F_TARGETS	0.429	1_KEGG_DNA_REPLICATION	0.429	1_KEGG_MISMATCH_REPAIR	0.429	
FLT1	2	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_BIOPOLYMER_METABOLIC_PROCESS	1.000	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1.000	2_DNA_REPLICATION	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	2_TRANSCRIPTION	1.000	
FLT4	4	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_CELL_CYCLE	0.750	1_KEGG_GLIOMA	0.750	1_KEGG_THYROID_CANCER	0.750	1_KEGG_SMALL_CELL_LUNG_CANCER	0.750	
FMOD	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_REPLICATION_FORK	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	
FN1	17	1_KEGG_FOCAL_ADHESION	0.882	1_KEGG_PATHWAYS_IN_CANCER	0.824	2_DNA_METABOLIC_PROCESS	0.765	1_KEGG_CELL_CYCLE	0.706	1_KEGG_ECM_RECEPTOR_INTERACTION	0.706	2_NUCLEUS	0.706	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	0.706	0_HALLMARK_G2M_CHECKPOINT	0.647	0_HALLMARK_E2F_TARGETS	0.647	1_KEGG_DNA_REPLICATION	0.647	
FNTA	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_THYROID_CANCER	1.000	2_NUCLEOPLASM	1.000	2_ORGANELLE_PART	1.000	
FOXA2	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	
FOXO4	1	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	
FRY	2	
FZD1	1	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	
FZD10	3	0_HALLMARK_HYPOXIA	0.333	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_FOCAL_ADHESION	0.333	
FZR1	2	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_APOPTOSIS	0.500	1_KEGG_MAPK_SIGNALING_PATHWAY	0.500	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	0.500	1_KEGG_AXON_GUIDANCE	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.500	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	
GAB3	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	
GABRB1	1	
GABRB3	3	0_HALLMARK_E2F_TARGETS	0.333	1_KEGG_MAPK_SIGNALING_PATHWAY	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_COLORECTAL_CANCER	0.333	1_KEGG_ENDOMETRIAL_CANCER	0.333	1_KEGG_PROSTATE_CANCER	0.333	2_NUCLEOPLASM	0.333	2_NUCLEAR_PART	0.333	
GDF15	1	
GDF2	1	
GDF5	5	2_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY	1.000	2_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY	1.000	
GDF9	1	2_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY	1.000	2_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY	1.000	
GEMIN4	1	2_SMALL_NUCLEAR_RIBONUCLEOPROTEIN_COMPLEX	1.000	
GFM1	1	
GFRA1	2	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_DNA_REPLICATION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	0.500	0_HALLMARK_MTORC1_SIGNALING	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_PYRIMIDINE_METABOLISM	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_PROTEASOME	0.500	
GINS1	1	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	2_NUCLEAR_REPLICATION_FORK	1.000	2_CHROMOSOMAL_PART	1.000	2_CHROMOSOME	1.000	2_DNA_REPLICATION	1.000	
GINS4	1	
GJD2	2	1_KEGG_GAP_JUNCTION	0.500	
GLI1	8	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_FOCAL_ADHESION	0.875	1_KEGG_ECM_RECEPTOR_INTERACTION	0.875	2_NUCLEUS	0.875	1_KEGG_COLORECTAL_CANCER	0.750	1_KEGG_PROSTATE_CANCER	0.750	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	0.750	1_KEGG_CELL_CYCLE	0.625	1_KEGG_SMALL_CELL_LUNG_CANCER	0.625	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.625	
GLI2	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_ORGANELLE_PART	1.000	2_NUCLEAR_PART	1.000	2_ORGANELLE_LUMEN	1.000	
GLI3	24	1_KEGG_PATHWAYS_IN_CANCER	0.958	1_KEGG_CELL_CYCLE	0.750	2_NUCLEUS	0.750	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_PROSTATE_CANCER	0.667	0_HALLMARK_G2M_CHECKPOINT	0.625	0_HALLMARK_E2F_TARGETS	0.625	1_KEGG_ECM_RECEPTOR_INTERACTION	0.583	1_KEGG_COLORECTAL_CANCER	0.583	2_DNA_METABOLIC_PROCESS	0.583	
GLIS3	7	0_HALLMARK_E2F_TARGETS	0.714	1_KEGG_DNA_REPLICATION	0.714	1_KEGG_CELL_CYCLE	0.714	1_KEGG_PATHWAYS_IN_CANCER	0.714	1_KEGG_COLORECTAL_CANCER	0.714	2_NUCLEUS	0.714	2_DNA_METABOLIC_PROCESS	0.714	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.714	0_HALLMARK_G2M_CHECKPOINT	0.571	0_HALLMARK_MYC_TARGETS_V1	0.571	
GLRB	1	2_SOLUBLE_FRACTION	1.000	2_LIGASE_ACTIVITY_FORMING_CARBON_OXYGEN_BONDS	1.000	
GMEB1	1	
GNA12	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	
GNAS	8	1_KEGG_PATHWAYS_IN_CANCER	0.875	0_HALLMARK_E2F_TARGETS	0.625	1_KEGG_CELL_CYCLE	0.625	1_KEGG_FOCAL_ADHESION	0.625	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	0.625	1_KEGG_COLORECTAL_CANCER	0.625	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.500	1_KEGG_ENDOMETRIAL_CANCER	0.500	
GNB2	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	
GNG12	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	
GP1BA	1	2_MEMBRANE_FRACTION	1.000	
GP6	4	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_PATHWAYS_IN_CANCER	0.750	1_KEGG_COLORECTAL_CANCER	0.750	2_NUCLEOPLASM	0.750	2_NUCLEAR_PART	0.750	2_ORGANELLE_LUMEN	0.750	2_NUCLEAR_LUMEN	0.750	2_NUCLEUS	0.750	2_MEMBRANE_ENCLOSED_LUMEN	0.750	
GPR50	1	
GRB10	1	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	2_NUCLEAR_PART	1.000	
GRIA1	3	1_KEGG_WNT_SIGNALING_PATHWAY	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_ENDOMETRIAL_CANCER	0.667	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_MYC_TARGETS_V2	0.333	1_KEGG_ERBB_SIGNALING_PATHWAY	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	0.333	
GRIA2	6	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_MAPK_SIGNALING_PATHWAY	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_COLORECTAL_CANCER	0.500	1_KEGG_PROSTATE_CANCER	0.500	2_SYSTEM_DEVELOPMENT	0.500	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.500	1_KEGG_CELL_CYCLE	0.333	
GRID2	1	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	1.000	2_GLUTAMATE_SIGNALING_PATHWAY	1.000	2_GLUTAMATE_RECEPTOR_ACTIVITY	1.000	2_IONOTROPIC_GLUTAMATE_RECEPTOR_ACTIVITY	1.000	
GRIK1	3	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_MISMATCH_REPAIR	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_NUCLEUS	0.667	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_CHROMOSOME	0.667	2_DNA_METABOLIC_PROCESS	0.667	
GRIK2	11	2_GLUTAMATE_SIGNALING_PATHWAY	0.909	2_GLUTAMATE_RECEPTOR_ACTIVITY	0.909	2_IONOTROPIC_GLUTAMATE_RECEPTOR_ACTIVITY	0.909	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	0.273	0_HALLMARK_DNA_REPAIR	0.091	0_HALLMARK_G2M_CHECKPOINT	0.091	0_HALLMARK_E2F_TARGETS	0.091	0_HALLMARK_MYC_TARGETS_V1	0.091	0_HALLMARK_MYC_TARGETS_V2	0.091	1_KEGG_PURINE_METABOLISM	0.091	
GRIK3	3	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.333	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	0_HALLMARK_IL2_STAT5_SIGNALING	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_APOPTOSIS	0.333	1_KEGG_AXON_GUIDANCE	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	
GRIK4	2	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.500	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	
GRIK5	4	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_MAPK_SIGNALING_PATHWAY	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_COLORECTAL_CANCER	0.500	1_KEGG_PROSTATE_CANCER	0.500	2_NUCLEUS	0.500	
GRIN1	6	1_KEGG_PATHWAYS_IN_CANCER	0.833	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_FOCAL_ADHESION	0.667	2_NUCLEUS	0.667	2_CHROMOSOMAL_PART	0.667	2_CHROMOSOME	0.667	2_DNA_METABOLIC_PROCESS	0.667	
GRIN2A	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_NUCLEAR_PART	1.000	2_NUCLEUS	1.000	2_NUCLEOLUS	1.000	2_CHROMOSOME	1.000	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1.000	
GRIN2B	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.500	1_KEGG_OOCYTE_MEIOSIS	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	0.500	1_KEGG_WNT_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_GAP_JUNCTION	0.500	
GRIN2C	3	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	2_DNA_METABOLIC_PROCESS	0.667	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	0.667	2_RESPONSE_TO_STRESS	0.667	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	0.667	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_MYC_TARGETS_V2	0.333	
GRIN3A	4	0_HALLMARK_DNA_REPAIR	0.250	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_E2F_TARGETS	0.250	0_HALLMARK_MYC_TARGETS_V1	0.250	0_HALLMARK_IL2_STAT5_SIGNALING	0.250	0_HALLMARK_ALLOGRAFT_REJECTION	0.250	1_KEGG_PYRIMIDINE_METABOLISM	0.250	1_KEGG_DNA_REPLICATION	0.250	1_KEGG_BASE_EXCISION_REPAIR	0.250	1_KEGG_MISMATCH_REPAIR	0.250	
GRIP1	1	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_AXON	1.000	2_CELL_PROJECTION	1.000	
GRM1	1	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_INTEGRIN_COMPLEX	1.000	
GRM7	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_GLIOMA	1.000	
GSK3A	1	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_P53_PATHWAY	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_NUCLEOLUS	1.000	
GSK3B	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
GSN	2	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	2_SYSTEM_DEVELOPMENT	1.000	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	1.000	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	
GTF2A1L	1	1_KEGG_BASAL_TRANSCRIPTION_FACTORS	1.000	
GTF2B	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_MTORC1_SIGNALING	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	
GTF2E1	1	2_NUCLEOPLASM	1.000	2_ORGANELLE_LUMEN	1.000	2_NUCLEAR_LUMEN	1.000	2_NUCLEUS	1.000	2_MEMBRANE_ENCLOSED_LUMEN	1.000	2_NUCLEOPLASM_PART	1.000	2_RNA_METABOLIC_PROCESS	1.000	2_BIOPOLYMER_METABOLIC_PROCESS	1.000	2_MACROMOLECULAR_COMPLEX_ASSEMBLY	1.000	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1.000	
GTF3C1	2	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_NUCLEUS	1.000	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_HEDGEHOG_SIGNALING	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_DNA_REPLICATION	0.500	
GTF3C2	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_THYROID_CANCER	1.000	
GUCY1A2	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	
GUCY2D	4	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	2_ORGANELLE_PART	0.500	2_NUCLEAR_PART	0.500	2_ORGANELLE_LUMEN	0.500	2_NUCLEAR_LUMEN	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_NUCLEUS	0.500	
GUCY2F	7	1_KEGG_P53_SIGNALING_PATHWAY	0.429	1_KEGG_FOCAL_ADHESION	0.429	1_KEGG_ECM_RECEPTOR_INTERACTION	0.429	1_KEGG_PATHWAYS_IN_CANCER	0.429	1_KEGG_COLORECTAL_CANCER	0.429	1_KEGG_ENDOMETRIAL_CANCER	0.429	1_KEGG_PROSTATE_CANCER	0.429	1_KEGG_SMALL_CELL_LUNG_CANCER	0.429	1_KEGG_APOPTOSIS	0.286	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.286	
HADHA	1	
HAP1	7	2_GLUTAMATE_RECEPTOR_ACTIVITY	0.571	2_IONOTROPIC_GLUTAMATE_RECEPTOR_ACTIVITY	0.571	
HCK	4	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_BIOPOLYMER_METABOLIC_PROCESS	1.000	1_KEGG_CELL_CYCLE	0.750	2_ORGANELLE_LUMEN	0.750	2_NUCLEUS	0.750	2_MEMBRANE_ENCLOSED_LUMEN	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_MISMATCH_REPAIR	0.500	
HCLS1	4	1_KEGG_APOPTOSIS	0.750	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	1_KEGG_PATHWAYS_IN_CANCER	0.750	1_KEGG_COLORECTAL_CANCER	0.750	1_KEGG_PROSTATE_CANCER	0.750	1_KEGG_SMALL_CELL_LUNG_CANCER	0.750	2_NUCLEUS	0.750	2_NUCLEOLUS	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	
HDAC1	1	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	1.000	0_HALLMARK_TGF_BETA_SIGNALING	1.000	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	
HDAC2	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	
HDAC4	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	
HDAC5	3	0_HALLMARK_APOPTOSIS	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_COLORECTAL_CANCER	0.667	1_KEGG_ENDOMETRIAL_CANCER	0.667	1_KEGG_PROSTATE_CANCER	0.667	
HDAC6	1	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_HEDGEHOG_SIGNALING	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_SYSTEM_DEVELOPMENT	1.000	
HDAC7	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_MYC_TARGETS_V2	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	2_NUCLEOPLASM	0.500	2_ORGANELLE_PART	0.500	2_NUCLEAR_CHROMOSOME	0.500	
HDAC9	2	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_NUCLEUS	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CHROMOSOMAL_PART	1.000	2_CHROMOSOME	1.000	2_DNA_METABOLIC_PROCESS	1.000	
HGS	1	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_MYOGENESIS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_HEDGEHOG_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
HHIP	1	
HIF1A	4	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	1.000	0_HALLMARK_MYC_TARGETS_V1	0.750	1_KEGG_DNA_REPLICATION	0.750	1_KEGG_PROSTATE_CANCER	0.750	2_ORGANELLE_PART	0.750	2_NUCLEAR_PART	0.750	
HIST3H3	1	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
HLA-A	5	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.800	0_HALLMARK_E2F_TARGETS	0.600	1_KEGG_CELL_CYCLE	0.600	1_KEGG_FOCAL_ADHESION	0.600	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.600	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	0.600	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.600	1_KEGG_COLORECTAL_CANCER	0.600	
HLA-DPA1	1	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	1.000	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	1.000	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
HLA-DQB1	1	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_ERBB_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	
HLA-DRA	1	0_HALLMARK_P53_PATHWAY	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_CELL_DEVELOPMENT	1.000	2_PROGRAMMED_CELL_DEATH	1.000	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	1.000	
HLA-DRB1	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	
HLA-G	1	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	2_NUCLEAR_PART	1.000	2_ORGANELLE_LUMEN	1.000	2_NUCLEAR_LUMEN	1.000	2_NUCLEUS	1.000	
HLTF	1	
HMGB2	1	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	2_NUCLEAR_PART	1.000	2_ORGANELLE_LUMEN	1.000	2_NUCLEAR_LUMEN	1.000	2_NUCLEUS	1.000	
HNRNPA1	1	1_KEGG_CELL_CYCLE	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_GLIOMA	1.000	
HNRNPA3	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	
HNRNPC	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	
HNRNPH1	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	1.000	2_INTEGRIN_COMPLEX	1.000	2_NEGATIVE_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	1.000	2_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	1.000	
HNRNPK	1	
HOXB1	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.667	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	0.667	
HOXD4	1	
HRAS	1	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_HEDGEHOG_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_MELANOGENESIS	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	
HSF1	1	
HSP90B1	3	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_COLORECTAL_CANCER	0.667	1_KEGG_DILATED_CARDIOMYOPATHY	0.667	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_HEDGEHOG_SIGNALING	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	1_KEGG_PURINE_METABOLISM	0.333	1_KEGG_DNA_REPLICATION	0.333	
HSPA1L	1	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	2_RESPONSE_TO_CHEMICAL_STIMULUS	1.000	2_RESPONSE_TO_BIOTIC_STIMULUS	1.000	
HSPA2	1	
HSPA6	1	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	2_RESPONSE_TO_BIOTIC_STIMULUS	1.000	
HSPG2	14	1_KEGG_PATHWAYS_IN_CANCER	0.929	1_KEGG_ECM_RECEPTOR_INTERACTION	0.857	1_KEGG_FOCAL_ADHESION	0.786	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.714	0_HALLMARK_G2M_CHECKPOINT	0.643	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.643	1_KEGG_COLORECTAL_CANCER	0.643	1_KEGG_PROSTATE_CANCER	0.643	2_NUCLEUS	0.643	0_HALLMARK_E2F_TARGETS	0.571	
HTT	14	1_KEGG_PATHWAYS_IN_CANCER	0.643	0_HALLMARK_E2F_TARGETS	0.571	1_KEGG_FOCAL_ADHESION	0.571	2_NUCLEUS	0.571	2_DNA_METABOLIC_PROCESS	0.571	2_BIOPOLYMER_METABOLIC_PROCESS	0.571	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.571	0_HALLMARK_G2M_CHECKPOINT	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	
HUS1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_HEDGEHOG_SIGNALING	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_MELANOMA	1.000	2_NUCLEOPLASM	1.000	
IARS	1	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	2_PLASMA_MEMBRANE_PART	1.000	2_PLASMA_MEMBRANE	1.000	
IFI16	6	1_KEGG_APOPTOSIS	0.833	1_KEGG_FOCAL_ADHESION	0.833	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.833	1_KEGG_PATHWAYS_IN_CANCER	0.833	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_AXON_GUIDANCE	0.667	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	0.667	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.667	2_SYSTEM_DEVELOPMENT	0.667	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.667	
IGF1R	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
IGFALS	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_NON_HOMOLOGOUS_END_JOINING	1.000	1_KEGG_CELL_CYCLE	1.000	
IHH	3	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.333	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	
IKBKB	2	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_MYC_TARGETS_V2	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_PYRIMIDINE_METABOLISM	0.500	
IKBKG	1	0_HALLMARK_APOPTOSIS	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	
IKZF1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_LATE	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
IKZF2	1	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_ERBB_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY	1.000	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
IKZF3	1	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	
IKZF4	2	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_MYC_TARGETS_V2	0.500	0_HALLMARK_IL2_STAT5_SIGNALING	0.500	1_KEGG_PURINE_METABOLISM	0.500	1_KEGG_PYRIMIDINE_METABOLISM	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_BASE_EXCISION_REPAIR	0.500	
IL11	1	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	
IL12RB1	2	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_NUCLEOLUS	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_BIOPOLYMER_METABOLIC_PROCESS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	
IL12RB2	2	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CHROMOSOME	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_DNA_REPAIR	1.000	
IL18	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_THYROID_CANCER	0.500	2_NUCLEOPLASM	0.500	2_ORGANELLE_PART	0.500	
IL2RB	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_NUCLEOLUS	1.000	0_HALLMARK_HYPOXIA	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_P53_PATHWAY	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	
IL2RG	4	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_MYC_TARGETS_V1	0.750	1_KEGG_CELL_CYCLE	0.750	2_NUCLEUS	0.750	2_DNA_METABOLIC_PROCESS	0.750	2_BIOPOLYMER_METABOLIC_PROCESS	0.750	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.750	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.750	2_DNA_REPLICATION	0.750	
IL31RA	1	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	2_TRANSMEMBRANE_RECEPTOR_ACTIVITY	1.000	2_HEMATOPOIETIN_INTERFERON_CLASSD200_DOMAIN_CYTOKINE_RECEPTOR_ACTIVITY	1.000	
IL6	1	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	
IL6ST	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	2_NUCLEAR_PART	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_NUCLEUS	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	
IL7R	1	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	
ILF3	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	2_ORGANELLE_PART	1.000	
IMP4	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_ERBB_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PANCREATIC_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	
INADL	2	1_KEGG_TIGHT_JUNCTION	1.000	2_TIGHT_JUNCTION	1.000	2_CALCIUM_INDEPENDENT_CELL_CELL_ADHESION	1.000	0_HALLMARK_APICAL_JUNCTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	0.500	2_CELL_JUNCTION	0.500	2_INTERCELLULAR_JUNCTION	0.500	2_APICAL_JUNCTION_COMPLEX	0.500	2_APICOLATERAL_PLASMA_MEMBRANE	0.500	
ING1	1	
ING4	1	
INHBA	2	2_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY	1.000	
INPPL1	2	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	
INSRR	1	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	
IPO4	6	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_HEDGEHOG_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	
IPO5	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	1_KEGG_PATHWAYS_IN_CANCER	0.750	2_NUCLEAR_PART	0.750	2_NUCLEAR_LUMEN	0.750	2_NUCLEUS	0.750	2_NUCLEOLUS	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	
IPO8	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_RNA_POLYMERASE	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	
IPO9	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	
IQGAP1	5	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.800	2_SYSTEM_DEVELOPMENT	0.800	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	0.800	1_KEGG_FOCAL_ADHESION	0.600	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	2_SIGNAL_TRANSDUCTION	0.600	2_ORGAN_DEVELOPMENT	0.600	
IRAK1	1	1_KEGG_APOPTOSIS	1.000	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	1.000	
IRF5	27	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_CELL_CYCLE	0.556	0_HALLMARK_E2F_TARGETS	0.519	1_KEGG_COLORECTAL_CANCER	0.519	1_KEGG_ENDOMETRIAL_CANCER	0.519	1_KEGG_PROSTATE_CANCER	0.481	2_NUCLEUS	0.481	2_BIOPOLYMER_METABOLIC_PROCESS	0.481	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.481	2_ORGANELLE_LUMEN	0.444	
IRF7	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_HEDGEHOG_SIGNALING	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_MELANOMA	1.000	2_NUCLEOPLASM	1.000	
IRS1	6	1_KEGG_PATHWAYS_IN_CANCER	1.000	0_HALLMARK_G2M_CHECKPOINT	0.833	0_HALLMARK_E2F_TARGETS	0.833	1_KEGG_DNA_REPLICATION	0.833	1_KEGG_CELL_CYCLE	0.833	1_KEGG_FOCAL_ADHESION	0.833	2_DNA_METABOLIC_PROCESS	0.833	2_BIOPOLYMER_METABOLIC_PROCESS	0.833	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	0.833	2_DNA_REPLICATION	0.833	
IRS2	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_MELANOMA	1.000	2_NUCLEAR_PART	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	
ISL1	1	
ITGA1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	
ITGA10	1	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	
ITGA3	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	
ITGA4	2	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	1.000	
ITGA5	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM	1.000	1_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	1.000	
ITGA6	1	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_HEDGEHOG_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_MELANOGENESIS	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	
ITGA7	2	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_MYOGENESIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	
ITGAD	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_P53_PATHWAY	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_INTEGRIN_COMPLEX	1.000	2_SYSTEM_DEVELOPMENT	1.000	
ITGAL	4	0_HALLMARK_E2F_TARGETS	1.000	2_NUCLEAR_PART	1.000	2_NUCLEUS	1.000	2_NUCLEOLUS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_MYC_TARGETS_V1	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	1_KEGG_PATHWAYS_IN_CANCER	0.750	2_ORGANELLE_PART	0.750	
ITGAM	5	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	2_BIOPOLYMER_METABOLIC_PROCESS	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_MYC_TARGETS_V1	0.800	1_KEGG_FOCAL_ADHESION	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.800	1_KEGG_COLORECTAL_CANCER	0.800	1_KEGG_ENDOMETRIAL_CANCER	0.800	
ITGAV	2	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_PROSTATE_CANCER	1.000	2_NUCLEUS	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	
ITGAX	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	
ITGB2	3	1_KEGG_COLORECTAL_CANCER	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	1_KEGG_CELL_CYCLE	0.667	1_KEGG_APOPTOSIS	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.667	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	0.667	1_KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	0.667	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.667	
ITGB3	3	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	2_NUCLEUS	1.000	
ITGB3BP	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	1.000	
ITGB4	3	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_MYC_TARGETS_V1	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_MISMATCH_REPAIR	0.667	
ITPKB	1	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	1.000	1_KEGG_CALCIUM_SIGNALING_PATHWAY	1.000	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	1.000	2_INOSITOL_OR_PHOSPHATIDYLINOSITOL_KINASE_ACTIVITY	1.000	
ITPR1	1	0_HALLMARK_NOTCH_SIGNALING	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	
IVL	2	1_KEGG_MAPK_SIGNALING_PATHWAY	0.500	1_KEGG_ERBB_SIGNALING_PATHWAY	0.500	1_KEGG_APOPTOSIS	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	0.500	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.500	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.500	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	0.500	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	0.500	
JAK1	3	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_SYSTEM_DEVELOPMENT	1.000	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	1.000	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_MYC_TARGETS_V1	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_CELL_CYCLE	0.667	
JAK2	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	1_KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM	1.000	1_KEGG_DILATED_CARDIOMYOPATHY	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_INTEGRIN_COMPLEX	1.000	
JAK3	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_MYC_TARGETS_V1	0.667	0_HALLMARK_MYC_TARGETS_V2	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	0.667	
JMJD1C	1	
JUNB	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_HEDGEHOG_SIGNALING	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_MELANOMA	1.000	2_NUCLEOPLASM	1.000	
KCNJ12	3	
KCNMA1	2	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_PROTEASOME	0.500	1_KEGG_MAPK_SIGNALING_PATHWAY	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_APOPTOSIS	0.500	
KCNMB1	1	
KCNN2	2	2_POTASSIUM_CHANNEL_ACTIVITY	1.000	
KCNN3	20	2_VOLTAGE_GATED_POTASSIUM_CHANNEL_COMPLEX	1.000	2_POTASSIUM_ION_TRANSPORT	1.000	2_POTASSIUM_CHANNEL_ACTIVITY	1.000	
KCNQ1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	
KCNQ2	5	1_KEGG_PATHWAYS_IN_CANCER	0.800	2_NUCLEUS	0.600	2_SYSTEM_DEVELOPMENT	0.600	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.600	2_DNA_REPLICATION	0.600	2_CELL_PROLIFERATION_GO_0008283	0.600	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	0.600	0_HALLMARK_DNA_REPAIR	0.400	0_HALLMARK_G2M_CHECKPOINT	0.400	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	0.400	
KCNQ3	8	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_CELL_CYCLE	0.750	2_NUCLEUS	0.750	2_CELL_PROLIFERATION_GO_0008283	0.750	0_HALLMARK_MYC_TARGETS_V1	0.625	1_KEGG_DNA_REPLICATION	0.625	1_KEGG_PATHWAYS_IN_CANCER	0.625	1_KEGG_COLORECTAL_CANCER	0.625	1_KEGG_PROSTATE_CANCER	0.625	2_NUCLEAR_PART	0.625	
KCNQ4	1	
KCNQ5	4	1_KEGG_FOCAL_ADHESION	0.250	1_KEGG_ECM_RECEPTOR_INTERACTION	0.250	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.250	1_KEGG_PATHWAYS_IN_CANCER	0.250	1_KEGG_SMALL_CELL_LUNG_CANCER	0.250	2_INTEGRIN_COMPLEX	0.250	
KHDRBS1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	
KIF3C	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	0_HALLMARK_KRAS_SIGNALING_UP	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	
KIT	3	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	1.000	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	1.000	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_COLORECTAL_CANCER	0.667	1_KEGG_PROSTATE_CANCER	0.667	1_KEGG_THYROID_CANCER	0.667	2_NUCLEAR_PART	0.667	
KLF1	7	1_KEGG_FOCAL_ADHESION	0.571	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.571	1_KEGG_PATHWAYS_IN_CANCER	0.571	1_KEGG_COLORECTAL_CANCER	0.571	1_KEGG_PROSTATE_CANCER	0.571	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.571	0_HALLMARK_G2M_CHECKPOINT	0.429	0_HALLMARK_E2F_TARGETS	0.429	1_KEGG_CELL_CYCLE	0.429	1_KEGG_ECM_RECEPTOR_INTERACTION	0.429	
KLF4	1	
KLRG1	1	
KPNA1	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	
KPNA5	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_HEDGEHOG_SIGNALING	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	
KPNA6	4	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_ENDOMETRIAL_CANCER	0.500	2_DNA_METABOLIC_PROCESS	0.500	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	0.500	2_RESPONSE_TO_STRESS	0.500	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	0.500	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.250	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_E2F_TARGETS	0.250	
KPNA7	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_APOPTOSIS	1.000	
KRAS	85	1_KEGG_PATHWAYS_IN_CANCER	0.965	1_KEGG_PROSTATE_CANCER	0.871	1_KEGG_COLORECTAL_CANCER	0.824	1_KEGG_ENDOMETRIAL_CANCER	0.741	1_KEGG_CELL_CYCLE	0.659	1_KEGG_SMALL_CELL_LUNG_CANCER	0.600	2_NUCLEUS	0.600	1_KEGG_FOCAL_ADHESION	0.576	2_CELL_PROLIFERATION_GO_0008283	0.576	0_HALLMARK_E2F_TARGETS	0.553	
KRR1	1	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_P53_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	
KRT1	18	
KRT2	6	0_HALLMARK_DNA_REPAIR	0.167	0_HALLMARK_G2M_CHECKPOINT	0.167	0_HALLMARK_E2F_TARGETS	0.167	0_HALLMARK_MYC_TARGETS_V1	0.167	0_HALLMARK_IL2_STAT5_SIGNALING	0.167	1_KEGG_PURINE_METABOLISM	0.167	1_KEGG_PYRIMIDINE_METABOLISM	0.167	1_KEGG_RNA_POLYMERASE	0.167	1_KEGG_DNA_REPLICATION	0.167	1_KEGG_BASE_EXCISION_REPAIR	0.167	
L1CAM	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	
LAMA1	10	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_CELL_CYCLE	0.800	0_HALLMARK_G2M_CHECKPOINT	0.700	0_HALLMARK_E2F_TARGETS	0.700	2_NUCLEUS	0.700	2_DNA_METABOLIC_PROCESS	0.700	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	1_KEGG_PROSTATE_CANCER	0.600	2_NON_MEMBRANE_BOUND_ORGANELLE	0.600	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.600	
LAMA2	2	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	0.500	0_HALLMARK_MTORC1_SIGNALING	0.500	0_HALLMARK_E2F_TARGETS	0.500	
LAMA3	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	
LAMA4	3	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	2_ORGANELLE_LUMEN	1.000	2_NUCLEAR_LUMEN	1.000	2_MEMBRANE_ENCLOSED_LUMEN	1.000	2_NUCLEOLUS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	
LAMA5	31	1_KEGG_PATHWAYS_IN_CANCER	0.806	1_KEGG_FOCAL_ADHESION	0.742	1_KEGG_ECM_RECEPTOR_INTERACTION	0.742	1_KEGG_CELL_CYCLE	0.645	0_HALLMARK_E2F_TARGETS	0.581	1_KEGG_COLORECTAL_CANCER	0.581	2_NUCLEUS	0.581	0_HALLMARK_G2M_CHECKPOINT	0.548	1_KEGG_PROSTATE_CANCER	0.548	1_KEGG_SMALL_CELL_LUNG_CANCER	0.548	
LAMB1	2	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	1.000	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	1.000	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	
LAMB2	1	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_SIGNAL_TRANSDUCTION	1.000	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	1.000	
LAMB4	3	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_NUCLEOLUS	1.000	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	1.000	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	
LAMC2	1	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_HEDGEHOG_SIGNALING_PATHWAY	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	
LAMC3	12	1_KEGG_PATHWAYS_IN_CANCER	0.917	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	1_KEGG_COLORECTAL_CANCER	0.750	1_KEGG_PROSTATE_CANCER	0.750	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ENDOMETRIAL_CANCER	0.667	2_NUCLEUS	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.583	
LATS2	1	
LCP2	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	
LHX2	2	
LHX4	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	
LIG1	1	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_GNRH_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	1_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	1.000	1_KEGG_DILATED_CARDIOMYOPATHY	1.000	
LIG4	5	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_E2F_TARGETS	0.800	0_HALLMARK_MYC_TARGETS_V1	0.800	1_KEGG_CELL_CYCLE	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.800	2_ORGANELLE_PART	0.800	2_NUCLEAR_PART	0.800	2_NON_MEMBRANE_BOUND_ORGANELLE	0.800	2_NUCLEUS	0.800	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.800	
LILRB3	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_HEDGEHOG_SIGNALING	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	
LIMD1	1	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	1_KEGG_OOCYTE_MEIOSIS	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_GAP_JUNCTION	1.000	1_KEGG_GNRH_SIGNALING_PATHWAY	1.000	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	1.000	1_KEGG_MELANOGENESIS	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	
LIMS1	1	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	1_KEGG_ERBB_SIGNALING_PATHWAY	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	1.000	1_KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY	1.000	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	
LIPE	1	
LMNB1	2	2_INTERMEDIATE_FILAMENT_CYTOSKELETON	0.500	2_INTERMEDIATE_FILAMENT	0.500	
LOR	1	2_CORNIFIED_ENVELOPE	1.000	2_KERATINOCYTE_DIFFERENTIATION	1.000	
LPAR3	1	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	
LRP1	4	1_KEGG_PATHWAYS_IN_CANCER	1.000	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.750	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.750	1_KEGG_COLORECTAL_CANCER	0.750	1_KEGG_ENDOMETRIAL_CANCER	0.750	1_KEGG_PROSTATE_CANCER	0.750	
LRP2	18	1_KEGG_PATHWAYS_IN_CANCER	0.944	0_HALLMARK_G2M_CHECKPOINT	0.667	2_DNA_METABOLIC_PROCESS	0.667	0_HALLMARK_E2F_TARGETS	0.611	1_KEGG_CELL_CYCLE	0.611	1_KEGG_FOCAL_ADHESION	0.611	2_NUCLEUS	0.611	2_NUCLEOLUS	0.611	2_BIOPOLYMER_METABOLIC_PROCESS	0.611	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.611	
LRP5	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	
LRPPRC	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_PROSTATE_CANCER	0.667	2_NUCLEAR_PART	0.667	2_NUCLEAR_LUMEN	0.667	2_NUCLEUS	0.667	2_NUCLEOLUS	0.667	
LTB	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	
LYAR	1	
LYN	2	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_ACUTE_MYELOID_LEUKEMIA	1.000	
LZTS1	1	1_KEGG_RNA_POLYMERASE	1.000	
MAD1L1	8	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_E2F_TARGETS	0.875	0_HALLMARK_G2M_CHECKPOINT	0.750	1_KEGG_PATHWAYS_IN_CANCER	0.750	2_CELL_CYCLE_GO_0007049	0.750	2_NUCLEUS	0.625	2_CHROMOSOMAL_PART	0.625	2_CHROMOSOME	0.625	2_DNA_METABOLIC_PROCESS	0.625	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.625	
MADD	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	
MAG	1	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_ESTROGEN_RESPONSE_LATE	1.000	0_HALLMARK_P53_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	
MAGEH1	1	
MAGI1	1	1_KEGG_TIGHT_JUNCTION	1.000	
MALT1	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	
MAML2	1	1_KEGG_NOTCH_SIGNALING_PATHWAY	1.000	
MAP1B	7	1_KEGG_PATHWAYS_IN_CANCER	1.000	0_HALLMARK_E2F_TARGETS	0.714	1_KEGG_CELL_CYCLE	0.714	1_KEGG_P53_SIGNALING_PATHWAY	0.714	1_KEGG_PROSTATE_CANCER	0.714	2_NUCLEAR_PART	0.714	2_NUCLEUS	0.714	2_NUCLEOLUS	0.714	2_BIOPOLYMER_METABOLIC_PROCESS	0.714	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.714	
MAP2	4	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	0_HALLMARK_DNA_REPAIR	0.250	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_APOPTOSIS	0.250	0_HALLMARK_MYOGENESIS	0.250	0_HALLMARK_E2F_TARGETS	0.250	0_HALLMARK_MYC_TARGETS_V1	0.250	
MAP2K1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_MTORC1_SIGNALING	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	
MAP2K4	9	1_KEGG_CELL_CYCLE	0.778	1_KEGG_PATHWAYS_IN_CANCER	0.778	1_KEGG_COLORECTAL_CANCER	0.778	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_MAPK_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.556	1_KEGG_PROSTATE_CANCER	0.556	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	0.556	2_NUCLEUS	0.556	2_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	0.556	
MAP2K6	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
MAP2K7	3	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_COLORECTAL_CANCER	0.667	1_KEGG_ENDOMETRIAL_CANCER	0.667	1_KEGG_PROSTATE_CANCER	0.667	2_NUCLEAR_PART	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_NUCLEUS	0.667	
MAP3K1	1	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	0_HALLMARK_KRAS_SIGNALING_UP	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_APOPTOSIS	1.000	
MAP3K10	3	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	2_DNA_REPLICATION	0.667	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	
MAP3K2	2	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_ERBB_SIGNALING_PATHWAY	0.500	1_KEGG_HEDGEHOG_SIGNALING_PATHWAY	0.500	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	0.500	
MAP3K4	4	1_KEGG_PATHWAYS_IN_CANCER	0.750	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_COLORECTAL_CANCER	0.500	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	0.500	
MAP3K5	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	2_CHROMOSOMAL_PART	1.000	2_CHROMOSOME	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_CELL_CYCLE_PROCESS	1.000	2_DNA_REPLICATION	1.000	2_CELL_CYCLE_GO_0007049	1.000	
MAP3K7	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	
MAPK10	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	1.000	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	1.000	
MAPK12	2	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_MYOGENESIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	
MAPK4	1	
MAPK6	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_DNA_REPLICATION	1.000	2_CELL_CYCLE_GO_0007049	1.000	0_HALLMARK_MYC_TARGETS_V1	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_APOPTOSIS	0.667	
MAPK8	5	1_KEGG_PATHWAYS_IN_CANCER	1.000	0_HALLMARK_APOPTOSIS	0.600	1_KEGG_FOCAL_ADHESION	0.600	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	1_KEGG_COLORECTAL_CANCER	0.600	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.600	0_HALLMARK_E2F_TARGETS	0.400	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.400	1_KEGG_DNA_REPLICATION	0.400	1_KEGG_MISMATCH_REPAIR	0.400	
MARK4	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	
MARS	2	1_KEGG_AMINOACYL_TRNA_BIOSYNTHESIS	0.500	2_LIGASE_ACTIVITY	0.500	2_LIGASE_ACTIVITY_FORMING_CARBON_OXYGEN_BONDS	0.500	
MASP1	1	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	1.000	
MAST2	1	
MATN1	2	
MAX	1	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_MELANOMA	1.000	
MCC	4	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_NUCLEOLUS	1.000	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	1.000	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_MYC_TARGETS_V1	0.750	1_KEGG_DNA_REPLICATION	0.750	
MCM10	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_NUCLEAR_PART	1.000	2_NUCLEAR_LUMEN	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_NUCLEUS	1.000	
MCM3AP	2	
MCM4	1	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	1_KEGG_HEDGEHOG_SIGNALING_PATHWAY	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_SYSTEM_DEVELOPMENT	1.000	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	1.000	2_DNA_REPLICATION	1.000	
MCM7	1	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	1.000	
MED12	6	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_NUCLEUS	1.000	1_KEGG_DNA_REPLICATION	0.833	2_BIOPOLYMER_METABOLIC_PROCESS	0.833	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.667	1_KEGG_COLORECTAL_CANCER	0.667	2_CHROMOSOME	0.667	
MED13	4	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_MYC_TARGETS_V1	0.750	1_KEGG_DNA_REPLICATION	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_PATHWAYS_IN_CANCER	0.750	2_ORGANELLE_PART	0.750	2_NUCLEAR_PART	0.750	2_ORGANELLE_LUMEN	0.750	2_NUCLEAR_LUMEN	0.750	
MED14	1	2_DNA_DIRECTED_RNA_POLYMERASEII_HOLOENZYME	1.000	2_TRANSCRIPTION_INITIATION	1.000	2_PROTEIN_DNA_COMPLEX_ASSEMBLY	1.000	2_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_II_PROMOTER	1.000	2_RNA_POLYMERASE_II_TRANSCRIPTION_MEDIATOR_ACTIVITY	1.000	2_GENERAL_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_ACTIVITY	1.000	
MED17	2	2_DNA_DIRECTED_RNA_POLYMERASEII_HOLOENZYME	1.000	2_TRANSCRIPTION_INITIATION	1.000	2_PROTEIN_DNA_COMPLEX_ASSEMBLY	1.000	2_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_II_PROMOTER	1.000	2_RNA_POLYMERASE_II_TRANSCRIPTION_MEDIATOR_ACTIVITY	1.000	2_GENERAL_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_ACTIVITY	1.000	
MED24	2	2_NUCLEOPLASM	1.000	2_ORGANELLE_LUMEN	1.000	2_NUCLEAR_LUMEN	1.000	2_NUCLEUS	1.000	2_MEMBRANE_ENCLOSED_LUMEN	1.000	2_NUCLEOPLASM_PART	1.000	2_RNA_METABOLIC_PROCESS	1.000	2_BIOPOLYMER_METABOLIC_PROCESS	1.000	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1.000	2_TRANSCRIPTION_DNA_DEPENDENT	1.000	
MEF2A	1	
MEIS1	3	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.333	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	0.333	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_APOPTOSIS	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	
MEIS2	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	
MET	3	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_NUCLEAR_PART	1.000	2_NUCLEAR_LUMEN	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	
MGP	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	
MICA	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	
MICAL1	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_HEDGEHOG_SIGNALING	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_PURINE_METABOLISM	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_CELL_CYCLE	0.500	
MITF	1	
MKNK2	1	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_THYROID_CANCER	1.000	
MLH1	2	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_NON_HOMOLOGOUS_END_JOINING	0.500	2_DNA_DEPENDENT_DNA_REPLICATION	0.500	2_PROTEIN_COMPLEX_BINDING	0.500	2_DOUBLE_STRANDED_DNA_BINDING	0.500	2_STRUCTURE_SPECIFIC_DNA_BINDING	0.500	
MLL	8	2_NUCLEUS	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.625	1_KEGG_PATHWAYS_IN_CANCER	0.625	2_DNA_METABOLIC_PROCESS	0.625	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.625	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.625	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_MAPK_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	
MLL3	13	
MLLT4	8	1_KEGG_PATHWAYS_IN_CANCER	0.875	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_COLORECTAL_CANCER	0.750	1_KEGG_DNA_REPLICATION	0.625	2_NUCLEUS	0.625	2_DNA_METABOLIC_PROCESS	0.625	2_DNA_REPLICATION	0.625	1_KEGG_FOCAL_ADHESION	0.500	
MME	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_GLIOMA	1.000	
MPDZ	2	1_KEGG_TIGHT_JUNCTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	2_CALCIUM_INDEPENDENT_CELL_CELL_ADHESION	0.500	2_CELL_CELL_ADHESION	0.500	
MRC1	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_APOPTOSIS	1.000	
MS4A1	1	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_AXON	1.000	2_CELL_PROJECTION	1.000	
MSH2	3	0_HALLMARK_E2F_TARGETS	1.000	2_DNA_METABOLIC_PROCESS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_MISMATCH_REPAIR	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_NUCLEUS	0.667	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.667	
MSH6	1	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	1_KEGG_ERBB_SIGNALING_PATHWAY	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	1.000	1_KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY	1.000	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	
MSN	2	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	2_NUCLEAR_PART	1.000	2_ORGANELLE_LUMEN	1.000	2_NUCLEAR_LUMEN	1.000	2_NUCLEUS	1.000	
MTA1	2	
MTA2	1	
MTA3	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	
MTDH	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_NUCLEAR_PART	1.000	2_ORGANELLE_LUMEN	1.000	2_NUCLEAR_LUMEN	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	
MUC2	2	
MUSK	1	
MXRA5	4	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_E2F_TARGETS	0.250	0_HALLMARK_MYC_TARGETS_V1	0.250	1_KEGG_PROTEASOME	0.250	1_KEGG_MAPK_SIGNALING_PATHWAY	0.250	1_KEGG_CELL_CYCLE	0.250	1_KEGG_OOCYTE_MEIOSIS	0.250	1_KEGG_P53_SIGNALING_PATHWAY	0.250	1_KEGG_APOPTOSIS	0.250	1_KEGG_WNT_SIGNALING_PATHWAY	0.250	
MXRA8	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	1.000	
MYBL1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_HEDGEHOG_SIGNALING	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_MELANOMA	1.000	2_NUCLEOPLASM	1.000	
MYBPC2	4	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.750	1_KEGG_PATHWAYS_IN_CANCER	0.750	1_KEGG_COLORECTAL_CANCER	0.750	1_KEGG_ENDOMETRIAL_CANCER	0.750	1_KEGG_PROSTATE_CANCER	0.750	1_KEGG_ERBB_SIGNALING_PATHWAY	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	0.500	
MYC	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	
MYF6	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	
MYH14	1	1_KEGG_TIGHT_JUNCTION	1.000	
MYH2	1	1_KEGG_TIGHT_JUNCTION	1.000	
MYH3	3	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	0.333	0_HALLMARK_MYC_TARGETS_V2	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	1_KEGG_MAPK_SIGNALING_PATHWAY	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_WNT_SIGNALING_PATHWAY	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	
MYH6	4	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	0.500	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_E2F_TARGETS	0.250	0_HALLMARK_MYC_TARGETS_V1	0.250	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.250	1_KEGG_DNA_REPLICATION	0.250	1_KEGG_MISMATCH_REPAIR	0.250	1_KEGG_CELL_CYCLE	0.250	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	0.250	1_KEGG_FOCAL_ADHESION	0.250	
MYH8	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_THYROID_CANCER	1.000	2_NUCLEOPLASM	1.000	2_ORGANELLE_PART	1.000	
MYH9	11	1_KEGG_PATHWAYS_IN_CANCER	0.909	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.727	2_NUCLEUS	0.727	0_HALLMARK_E2F_TARGETS	0.636	1_KEGG_DNA_REPLICATION	0.636	1_KEGG_CELL_CYCLE	0.636	1_KEGG_FOCAL_ADHESION	0.636	2_DNA_METABOLIC_PROCESS	0.636	2_SYSTEM_DEVELOPMENT	0.636	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.636	
MYL1	2	
MYLK	9	1_KEGG_PATHWAYS_IN_CANCER	0.444	1_KEGG_PROSTATE_CANCER	0.444	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.444	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_FOCAL_ADHESION	0.333	
MYLK3	1	
MYO1C	1	2_CELL_PROJECTION	1.000	
MYO1E	2	2_CELL_PROJECTION	0.500	
MYO1F	1	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	
MYO5A	4	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_MYC_TARGETS_V2	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_CELL_CYCLE	0.500	2_NUCLEOPLASM	0.500	2_ORGANELLE_PART	0.500	2_NUCLEAR_PART	0.500	
MYOD1	2	1_KEGG_APOPTOSIS	1.000	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_NUCLEUS	1.000	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1.000	
NAP1L1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_LATE	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
NCAM1	5	0_HALLMARK_E2F_TARGETS	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.800	2_NUCLEOLUS	0.800	2_BIOPOLYMER_METABOLIC_PROCESS	0.800	0_HALLMARK_MYC_TARGETS_V1	0.600	1_KEGG_DNA_REPLICATION	0.600	1_KEGG_MISMATCH_REPAIR	0.600	1_KEGG_CELL_CYCLE	0.600	1_KEGG_APOPTOSIS	0.600	1_KEGG_FOCAL_ADHESION	0.600	
NCAM2	1	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PANCREATIC_CANCER	1.000	1_KEGG_BLADDER_CANCER	1.000	
NCL	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	1.000	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	1.000	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	
NCOA1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_NON_HOMOLOGOUS_END_JOINING	1.000	1_KEGG_CELL_CYCLE	1.000	
NCOA2	3	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_APOPTOSIS	0.667	1_KEGG_WNT_SIGNALING_PATHWAY	0.667	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.667	
NCOA6	5	1_KEGG_FOCAL_ADHESION	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.800	1_KEGG_SMALL_CELL_LUNG_CANCER	0.800	1_KEGG_MAPK_SIGNALING_PATHWAY	0.600	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.600	1_KEGG_COLORECTAL_CANCER	0.600	1_KEGG_PROSTATE_CANCER	0.600	2_NUCLEUS	0.600	0_HALLMARK_DNA_REPAIR	0.400	
NCOR1	12	1_KEGG_PATHWAYS_IN_CANCER	0.833	1_KEGG_FOCAL_ADHESION	0.750	2_NUCLEUS	0.750	1_KEGG_CELL_CYCLE	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_DNA_METABOLIC_PROCESS	0.667	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.667	0_HALLMARK_G2M_CHECKPOINT	0.583	0_HALLMARK_E2F_TARGETS	0.583	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.583	
NCOR2	25	1_KEGG_PATHWAYS_IN_CANCER	0.800	2_NUCLEUS	0.760	1_KEGG_CELL_CYCLE	0.720	1_KEGG_FOCAL_ADHESION	0.720	0_HALLMARK_G2M_CHECKPOINT	0.680	0_HALLMARK_E2F_TARGETS	0.680	1_KEGG_ECM_RECEPTOR_INTERACTION	0.680	1_KEGG_DNA_REPLICATION	0.640	2_NON_MEMBRANE_BOUND_ORGANELLE	0.640	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.640	
NCSTN	1	0_HALLMARK_APOPTOSIS	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	
NDN	1	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	1.000	0_HALLMARK_TGF_BETA_SIGNALING	1.000	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	
NEB	19	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	0.684	1_KEGG_PATHWAYS_IN_CANCER	0.316	1_KEGG_COLORECTAL_CANCER	0.316	1_KEGG_ENDOMETRIAL_CANCER	0.316	2_SARCOMERE	0.316	2_CONTRACTILE_FIBER	0.316	2_MYOFIBRIL	0.316	2_CONTRACTILE_FIBER_PART	0.316	2_STRUCTURAL_MOLECULE_ACTIVITY	0.316	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.263	
NEDD4L	4	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	0.750	0_HALLMARK_IL2_STAT5_SIGNALING	0.250	1_KEGG_CELL_CYCLE	0.250	1_KEGG_P53_SIGNALING_PATHWAY	0.250	1_KEGG_APOPTOSIS	0.250	1_KEGG_FOCAL_ADHESION	0.250	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.250	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.250	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	0.250	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.250	
NEFH	67	1_KEGG_PATHWAYS_IN_CANCER	0.507	1_KEGG_CELL_CYCLE	0.433	1_KEGG_COLORECTAL_CANCER	0.433	2_NUCLEUS	0.433	0_HALLMARK_E2F_TARGETS	0.418	2_AXON	0.403	2_BIOPOLYMER_METABOLIC_PROCESS	0.403	0_HALLMARK_G2M_CHECKPOINT	0.388	1_KEGG_PROSTATE_CANCER	0.388	2_NUCLEAR_PART	0.388	
NEFL	1	
NEFM	7	1_KEGG_CELL_CYCLE	0.857	1_KEGG_PATHWAYS_IN_CANCER	0.857	0_HALLMARK_G2M_CHECKPOINT	0.714	0_HALLMARK_E2F_TARGETS	0.714	1_KEGG_COLORECTAL_CANCER	0.714	2_NON_MEMBRANE_BOUND_ORGANELLE	0.714	2_NUCLEUS	0.714	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.714	2_DNA_METABOLIC_PROCESS	0.714	2_DNA_REPAIR	0.714	
NFATC1	5	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.600	1_KEGG_PATHWAYS_IN_CANCER	0.600	2_SYSTEM_DEVELOPMENT	0.600	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.600	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	0.600	0_HALLMARK_E2F_TARGETS	0.400	1_KEGG_MAPK_SIGNALING_PATHWAY	0.400	1_KEGG_AXON_GUIDANCE	0.400	1_KEGG_FOCAL_ADHESION	0.400	1_KEGG_ECM_RECEPTOR_INTERACTION	0.400	
NFATC2	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_RNA_POLYMERASE	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	
NFIB	2	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_AXON_GUIDANCE	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	
NFIC	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
NFKB1	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	
NGEF	1	0_HALLMARK_NOTCH_SIGNALING	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	
NGF	2	1_KEGG_APOPTOSIS	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_HEDGEHOG_SIGNALING	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_PURINE_METABOLISM	0.500	1_KEGG_PYRIMIDINE_METABOLISM	0.500	1_KEGG_DNA_REPLICATION	0.500	
NGFR	2	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_NUCLEUS	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	1.000	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	0.500	0_HALLMARK_E2F_TARGETS	0.500	
NID1	10	1_KEGG_PATHWAYS_IN_CANCER	0.700	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	2_NUCLEAR_PART	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_NUCLEUS	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	
NLGN1	2	
NLRP12	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_THYROID_CANCER	1.000	
NMT1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PANCREATIC_CANCER	1.000	
NOS1	5	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CHROMOSOME	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	1.000	
NOS2	2	
NOTCH1	7	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_DNA_REPLICATION	0.857	0_HALLMARK_G2M_CHECKPOINT	0.714	0_HALLMARK_E2F_TARGETS	0.714	1_KEGG_CELL_CYCLE	0.714	1_KEGG_FOCAL_ADHESION	0.714	1_KEGG_PROSTATE_CANCER	0.714	2_NUCLEUS	0.714	2_NUCLEOLUS	0.714	2_DNA_METABOLIC_PROCESS	0.714	
NOTCH2	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	
NOTCH3	12	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	0_HALLMARK_E2F_TARGETS	0.417	0_HALLMARK_MYC_TARGETS_V1	0.417	1_KEGG_CELL_CYCLE	0.417	2_NUCLEUS	0.417	2_SYSTEM_DEVELOPMENT	0.417	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.417	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	0.417	
NOV	3	1_KEGG_MAPK_SIGNALING_PATHWAY	0.333	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	0.333	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.333	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	0.333	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_ENDOMETRIAL_CANCER	0.333	2_PLASMA_MEMBRANE_PART	0.333	2_PLASMA_MEMBRANE	0.333	
NOX3	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	
NPM1	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	2_NUCLEUS	1.000	2_NUCLEOLUS	1.000	
NPR1	1	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_ERBB_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY	1.000	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
NR3C1	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_ACUTE_MYELOID_LEUKEMIA	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_COLLAGEN	1.000	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	1.000	2_ORGAN_DEVELOPMENT	1.000	
NR3C2	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	
NR5A1	2	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	1.000	2_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	1.000	2_REGULATION_OF_METABOLIC_PROCESS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	
NR5A2	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	1.000	
NRAS	7	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_P53_SIGNALING_PATHWAY	0.857	1_KEGG_ENDOMETRIAL_CANCER	0.857	1_KEGG_PROSTATE_CANCER	0.857	0_HALLMARK_E2F_TARGETS	0.714	1_KEGG_CELL_CYCLE	0.714	1_KEGG_COLORECTAL_CANCER	0.714	1_KEGG_SMALL_CELL_LUNG_CANCER	0.714	2_CELL_PROLIFERATION_GO_0008283	0.714	1_KEGG_FOCAL_ADHESION	0.571	
NRG1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_ORGANELLE_PART	1.000	
NRXN1	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_MYC_TARGETS_V1	0.667	1_KEGG_PYRIMIDINE_METABOLISM	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_BASE_EXCISION_REPAIR	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_COLORECTAL_CANCER	0.667	1_KEGG_PROSTATE_CANCER	0.667	
NRXN2	1	
NRXN3	3	0_HALLMARK_E2F_TARGETS	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_MISMATCH_REPAIR	0.333	1_KEGG_MAPK_SIGNALING_PATHWAY	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_APOPTOSIS	0.333	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_ENDOMETRIAL_CANCER	0.333	
NSMAF	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_NUCLEAR_PART	1.000	2_ORGANELLE_LUMEN	1.000	2_NUCLEAR_LUMEN	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_NUCLEUS	1.000	
NSUN2	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_NUCLEOLUS	1.000	2_TRANSFERASE_ACTIVITY_TRANSFERRING_PHOSPHORUS_CONTAINING_GROUPS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_CELL_CYCLE	0.500	
NTRK1	2	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_BIOPOLYMER_METABOLIC_PROCESS	1.000	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1.000	2_TRANSCRIPTION	1.000	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	1.000	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	1.000	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	
NUMB	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_MYC_TARGETS_V1	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.667	1_KEGG_MISMATCH_REPAIR	0.667	1_KEGG_CELL_CYCLE	0.667	2_NUCLEAR_PART	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_NUCLEUS	0.667	
NUP133	1	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	
NUP153	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_NUCLEUS	1.000	2_NUCLEOLUS	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_BIOPOLYMER_METABOLIC_PROCESS	1.000	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1.000	
NUP214	5	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_E2F_TARGETS	0.800	0_HALLMARK_MYC_TARGETS_V1	0.800	1_KEGG_CELL_CYCLE	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.800	1_KEGG_COLORECTAL_CANCER	0.800	1_KEGG_PROSTATE_CANCER	0.800	2_NUCLEAR_PART	0.800	2_NUCLEAR_LUMEN	0.800	2_NUCLEUS	0.800	
NUP98	2	0_HALLMARK_MYC_TARGETS_V1	1.000	2_NUCLEUS	1.000	2_MACROMOLECULAR_COMPLEX	1.000	2_PROTEIN_COMPLEX	1.000	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_MTORC1_SIGNALING	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_DNA_REPLICATION	0.500	
OBSCN	1	
OCLN	1	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_TIGHT_JUNCTION	1.000	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	1.000	2_CELL_JUNCTION	1.000	2_TIGHT_JUNCTION	1.000	2_INTERCELLULAR_JUNCTION	1.000	2_APICAL_JUNCTION_COMPLEX	1.000	2_APICOLATERAL_PLASMA_MEMBRANE	1.000	2_CALCIUM_INDEPENDENT_CELL_CELL_ADHESION	1.000	2_CELL_CELL_ADHESION	1.000	
OCRL	1	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_PROSTATE_CANCER	1.000	
ODC1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	
ODZ1	2	
OPRD1	2	
OTX2	1	
PAK2	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	
PAK4	2	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	2_NUCLEUS	1.000	
PAPPA	3	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	2_NUCLEUS	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_BIOPOLYMER_METABOLIC_PROCESS	1.000	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1.000	2_DNA_REPLICATION	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	1.000	
PAPPA2	4	0_HALLMARK_G2M_CHECKPOINT	1.000	2_NUCLEAR_PART	1.000	2_NUCLEAR_LUMEN	1.000	2_NUCLEUS	1.000	2_NUCLEOLUS	1.000	2_DNA_METABOLIC_PROCESS	1.000	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_MYC_TARGETS_V1	0.750	1_KEGG_DNA_REPLICATION	0.750	1_KEGG_BASE_EXCISION_REPAIR	0.750	
PARK2	1	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	
PARP1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_MTORC1_SIGNALING	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	
PARVB	1	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	
PARVG	1	2_CELL_SUBSTRATE_ADHESION	1.000	2_CELL_MATRIX_ADHESION	1.000	
PAX3	2	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	0_HALLMARK_HYPOXIA	0.500	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_MYC_TARGETS_V2	0.500	
PAX4	1	0_HALLMARK_G2M_CHECKPOINT	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PANCREATIC_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	
PAX5	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	
PAX6	6	1_KEGG_PATHWAYS_IN_CANCER	0.833	1_KEGG_CELL_CYCLE	0.667	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_AXON_GUIDANCE	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PROSTATE_CANCER	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_NUCLEAR_PART	0.500	
PAX8	3	2_NUCLEUS	1.000	2_TRANSCRIPTION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_MYC_TARGETS_V1	0.667	0_HALLMARK_MYC_TARGETS_V2	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_MISMATCH_REPAIR	0.667	1_KEGG_CELL_CYCLE	0.667	
PBX1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_LATE	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
PBX2	2	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_MYC_TARGETS_V2	0.500	0_HALLMARK_IL2_STAT5_SIGNALING	0.500	
PCDH1	2	
PCDH10	5	0_HALLMARK_NOTCH_SIGNALING	0.200	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	0.200	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.200	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	0.200	1_KEGG_P53_SIGNALING_PATHWAY	0.200	1_KEGG_WNT_SIGNALING_PATHWAY	0.200	1_KEGG_FOCAL_ADHESION	0.200	1_KEGG_ECM_RECEPTOR_INTERACTION	0.200	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	0.200	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.200	
PCDH11X	1	
PCDH11Y	6	
PCDH15	5	
PCDH17	15	1_KEGG_TIGHT_JUNCTION	0.133	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	0.133	2_CELL_JUNCTION	0.133	2_TIGHT_JUNCTION	0.133	2_INTERCELLULAR_JUNCTION	0.133	2_APICAL_JUNCTION_COMPLEX	0.133	2_APICOLATERAL_PLASMA_MEMBRANE	0.133	2_CALCIUM_INDEPENDENT_CELL_CELL_ADHESION	0.133	2_CELL_CELL_ADHESION	0.133	0_HALLMARK_APICAL_JUNCTION	0.067	
PCDH18	1	
PCDH19	1	
PCDH9	1	
PCDHA1	1	
PCDHA11	2	
PCDHA12	1	
PCDHA2	5	
PCDHA3	6	
PCDHA4	1	
PCDHA5	2	
PCDHA6	3	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_IL2_STAT5_SIGNALING	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_PROTEASOME	0.333	1_KEGG_BASE_EXCISION_REPAIR	0.333	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.333	1_KEGG_MISMATCH_REPAIR	0.333	1_KEGG_CELL_CYCLE	0.333	
PCDHA7	14	
PCDHA9	1	
PCDHAC2	2	
PCDHB12	2	
PCDHB13	1	
PCDHB3	1	
PCDHB5	1	
PCDHB6	1	
PCDHB8	10	
PCDHGA1	1	
PCDHGA10	1	
PCDHGA11	2	
PCDHGA4	1	
PCDHGA5	3	
PCDHGA6	1	
PCDHGA9	1	
PCDHGB4	1	
PCDHGB5	3	
PCDHGB6	1	
PDC	1	
PDCD4	1	
PDGFA	1	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	
PDGFRA	6	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.833	1_KEGG_PROSTATE_CANCER	0.833	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_COLORECTAL_CANCER	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	
PDGFRB	3	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_MELANOMA	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.667	1_KEGG_PROSTATE_CANCER	0.667	2_ORGANELLE_PART	0.667	
PDZD2	6	
PEG3	3	
PGM1	2	2_ISOMERASE_ACTIVITY	1.000	
PGM5	1	2_ISOMERASE_ACTIVITY	1.000	
PGR	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	
PHF17	1	
PHKB	1	
PI4KA	1	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	
PI4KB	3	0_HALLMARK_DNA_REPAIR	0.333	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_MYC_TARGETS_V2	0.333	1_KEGG_PURINE_METABOLISM	0.333	1_KEGG_PYRIMIDINE_METABOLISM	0.333	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_MISMATCH_REPAIR	0.333	
PIAS3	1	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	1.000	2_CELL_CYCLE_ARREST_GO_0007050	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	
PIK3C2B	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	
PIK3C2G	1	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	1.000	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	1.000	
PIK3CA	56	1_KEGG_PATHWAYS_IN_CANCER	0.982	1_KEGG_PROSTATE_CANCER	0.839	1_KEGG_COLORECTAL_CANCER	0.768	1_KEGG_FOCAL_ADHESION	0.714	1_KEGG_SMALL_CELL_LUNG_CANCER	0.696	1_KEGG_CELL_CYCLE	0.679	1_KEGG_ENDOMETRIAL_CANCER	0.679	2_NUCLEUS	0.589	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.554	2_CELL_PROLIFERATION_GO_0008283	0.554	
PIK3CB	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	1.000	
PIK3CD	6	1_KEGG_PATHWAYS_IN_CANCER	1.000	0_HALLMARK_G2M_CHECKPOINT	0.833	0_HALLMARK_E2F_TARGETS	0.833	1_KEGG_DNA_REPLICATION	0.833	1_KEGG_CELL_CYCLE	0.833	1_KEGG_FOCAL_ADHESION	0.833	1_KEGG_PROSTATE_CANCER	0.833	2_CHROMOSOMAL_PART	0.833	2_CHROMOSOME	0.833	2_DNA_METABOLIC_PROCESS	0.833	
PIK3CG	7	1_KEGG_PATHWAYS_IN_CANCER	1.000	0_HALLMARK_G2M_CHECKPOINT	0.857	0_HALLMARK_E2F_TARGETS	0.857	1_KEGG_CELL_CYCLE	0.857	1_KEGG_COLORECTAL_CANCER	0.857	2_DNA_METABOLIC_PROCESS	0.857	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.714	2_NUCLEUS	0.714	2_DNA_REPLICATION	0.714	1_KEGG_DNA_REPLICATION	0.571	
PIK3R1	9	1_KEGG_CELL_CYCLE	0.889	1_KEGG_PATHWAYS_IN_CANCER	0.889	0_HALLMARK_G2M_CHECKPOINT	0.778	0_HALLMARK_E2F_TARGETS	0.778	1_KEGG_FOCAL_ADHESION	0.778	2_NUCLEUS	0.778	2_CELL_PROLIFERATION_GO_0008283	0.778	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	0.778	1_KEGG_COLORECTAL_CANCER	0.667	1_KEGG_ENDOMETRIAL_CANCER	0.667	
PIK3R2	1	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	1_KEGG_HEDGEHOG_SIGNALING_PATHWAY	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_SYSTEM_DEVELOPMENT	1.000	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	1.000	2_DNA_REPLICATION	1.000	
PIK3R3	2	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	2_NUCLEUS	1.000	2_BIOPOLYMER_METABOLIC_PROCESS	1.000	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	1.000	
PIK3R5	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	
PIN1	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
PIP4K2A	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	0_HALLMARK_HYPOXIA	0.500	0_HALLMARK_P53_PATHWAY	0.500	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	
PIP4K2B	1	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_MYOGENESIS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_HEDGEHOG_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
PIP5K1C	6	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	0_HALLMARK_E2F_TARGETS	0.833	2_NON_MEMBRANE_BOUND_ORGANELLE	0.833	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.833	2_CHROMOSOME	0.833	0_HALLMARK_G2M_CHECKPOINT	0.667	1_KEGG_DNA_REPLICATION	0.667	2_ORGANELLE_PART	0.667	2_NUCLEAR_PART	0.667	
PLAT	1	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_HEDGEHOG_SIGNALING	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_SYSTEM_DEVELOPMENT	1.000	
PLAU	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	
PLCB1	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	0.500	1_KEGG_MAPK_SIGNALING_PATHWAY	0.500	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_AXON_GUIDANCE	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	
PLCB2	1	
PLCB3	1	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
PLCE1	2	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_SIGNAL_TRANSDUCTION	1.000	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_HEDGEHOG_SIGNALING	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_INFLAMMATORY_RESPONSE	0.500	0_HALLMARK_IL2_STAT5_SIGNALING	0.500	1_KEGG_PYRIMIDINE_METABOLISM	0.500	
PLCG1	5	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.800	2_NUCLEUS	0.800	2_DNA_REPLICATION	0.800	0_HALLMARK_G2M_CHECKPOINT	0.600	0_HALLMARK_E2F_TARGETS	0.600	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.600	1_KEGG_DNA_REPLICATION	0.600	
PLCG2	6	1_KEGG_ECM_RECEPTOR_INTERACTION	0.833	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_NUCLEUS	0.667	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_DNA_METABOLIC_PROCESS	0.667	2_DNA_REPAIR	0.667	
PLCZ1	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
PLEK	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	
PLG	7	1_KEGG_FOCAL_ADHESION	0.714	1_KEGG_ECM_RECEPTOR_INTERACTION	0.714	1_KEGG_PATHWAYS_IN_CANCER	0.714	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	0.714	0_HALLMARK_E2F_TARGETS	0.571	1_KEGG_DNA_REPLICATION	0.571	1_KEGG_MISMATCH_REPAIR	0.571	1_KEGG_CELL_CYCLE	0.571	1_KEGG_COLORECTAL_CANCER	0.571	1_KEGG_PROSTATE_CANCER	0.571	
PLS3	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PANCREATIC_CANCER	1.000	
PLXNA1	1	1_KEGG_AXON_GUIDANCE	1.000	
PLXNA4	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	1.000	
PLXNB3	10	0_HALLMARK_G2M_CHECKPOINT	0.700	0_HALLMARK_E2F_TARGETS	0.700	1_KEGG_CELL_CYCLE	0.700	1_KEGG_PATHWAYS_IN_CANCER	0.700	1_KEGG_AXON_GUIDANCE	0.600	2_BIOPOLYMER_METABOLIC_PROCESS	0.600	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.600	1_KEGG_APOPTOSIS	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	
PLXND1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_NON_HOMOLOGOUS_END_JOINING	1.000	
PML	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_HEDGEHOG_SIGNALING	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_MELANOMA	1.000	2_NUCLEOPLASM	1.000	
POLA2	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	
POLB	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	
POLD1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	
POLE	7	1_KEGG_DNA_REPLICATION	0.857	0_HALLMARK_E2F_TARGETS	0.571	0_HALLMARK_G2M_CHECKPOINT	0.429	0_HALLMARK_MYC_TARGETS_V1	0.429	1_KEGG_CELL_CYCLE	0.429	2_NUCLEUS	0.429	2_NUCLEOLUS	0.429	2_DNA_METABOLIC_PROCESS	0.429	2_BIOPOLYMER_METABOLIC_PROCESS	0.429	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.429	
POLE2	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	1.000	1_KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	1.000	
POLR1A	3	1_KEGG_RNA_POLYMERASE	0.667	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.333	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_PROTEASOME	0.333	1_KEGG_CELL_CYCLE	0.333	
POLR1D	1	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	
POLR2A	7	0_HALLMARK_E2F_TARGETS	0.857	1_KEGG_DNA_REPLICATION	0.857	1_KEGG_MISMATCH_REPAIR	0.857	2_NUCLEAR_PART	0.857	2_NON_MEMBRANE_BOUND_ORGANELLE	0.857	2_NUCLEUS	0.857	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.857	2_DNA_METABOLIC_PROCESS	0.857	2_DNA_REPAIR	0.857	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	0.857	
POLR3A	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_RNA_POLYMERASE	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	
POLR3B	2	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	0.500	1_KEGG_PURINE_METABOLISM	0.500	1_KEGG_PYRIMIDINE_METABOLISM	0.500	1_KEGG_RNA_POLYMERASE	0.500	1_KEGG_HEDGEHOG_SIGNALING_PATHWAY	0.500	1_KEGG_AXON_GUIDANCE	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY	0.500	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.500	
POLR3E	5	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	2_NUCLEUS	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_BIOPOLYMER_METABOLIC_PROCESS	1.000	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	1.000	2_DNA_REPLICATION	1.000	
POU2F1	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_APOPTOSIS	1.000	
POU3F3	1	1_KEGG_RENAL_CELL_CARCINOMA	1.000	2_RESPONSE_TO_HYPOXIA	1.000	
POU5F1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	
PPARG	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	
PPARGC1A	5	0_HALLMARK_G2M_CHECKPOINT	0.600	0_HALLMARK_E2F_TARGETS	0.600	0_HALLMARK_MYC_TARGETS_V1	0.600	1_KEGG_CELL_CYCLE	0.600	1_KEGG_FOCAL_ADHESION	0.600	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	1_KEGG_PATHWAYS_IN_CANCER	0.600	1_KEGG_PROSTATE_CANCER	0.600	2_NON_MEMBRANE_BOUND_ORGANELLE	0.600	2_NUCLEUS	0.600	
PPFIA1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_MTORC1_SIGNALING	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_CIRCADIAN_RHYTHM_MAMMAL	1.000	
PPFIA2	2	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_IL2_STAT5_SIGNALING	0.500	1_KEGG_PURINE_METABOLISM	0.500	1_KEGG_PYRIMIDINE_METABOLISM	0.500	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_BASE_EXCISION_REPAIR	0.500	
PPL	1	
PPP1R12A	2	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_PYRIMIDINE_METABOLISM	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_BASE_EXCISION_REPAIR	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	
PPP2R5D	1	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	
PPP3CA	1	0_HALLMARK_MTORC1_SIGNALING	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_CALCIUM_SIGNALING_PATHWAY	1.000	1_KEGG_OOCYTE_MEIOSIS	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_MELANOGENESIS	1.000	2_NUCLEUS	1.000	2_MACROMOLECULAR_COMPLEX	1.000	2_PROTEIN_COMPLEX	1.000	
PRKAA2	1	
PRKACG	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_DILATED_CARDIOMYOPATHY	1.000	0_HALLMARK_MYC_TARGETS_V1	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.667	
PRKAG1	1	
PRKCB	5	1_KEGG_CELL_CYCLE	0.800	1_KEGG_FOCAL_ADHESION	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.800	1_KEGG_COLORECTAL_CANCER	0.800	2_SYSTEM_DEVELOPMENT	0.800	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.800	1_KEGG_MAPK_SIGNALING_PATHWAY	0.600	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.600	1_KEGG_PROSTATE_CANCER	0.600	
PRKCG	3	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	2_NUCLEAR_PART	1.000	2_ORGANELLE_LUMEN	1.000	2_NUCLEAR_LUMEN	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_NUCLEUS	1.000	
PRKCQ	1	0_HALLMARK_G2M_CHECKPOINT	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_BLADDER_CANCER	1.000	2_ORGANELLE_LUMEN	1.000	2_NUCLEAR_LUMEN	1.000	2_MEMBRANE_ENCLOSED_LUMEN	1.000	
PRKG1	2	
PRKG2	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	
PRKX	4	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	1.000	2_NUCLEAR_PART	1.000	2_ORGANELLE_LUMEN	1.000	2_NUCLEAR_LUMEN	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_NUCLEUS	1.000	
PRLR	2	
PRMT2	1	
PSEN2	1	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	
PSG1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	1.000	2_NUCLEAR_PART	1.000	2_ORGANELLE_LUMEN	1.000	2_NUCLEAR_LUMEN	1.000	
PSMB1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	1.000	
PSMB8	4	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CHROMOSOMAL_PART	1.000	2_CHROMOSOME	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	1.000	
PSMC4	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_APOPTOSIS	1.000	
PSMC5	2	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	2_ORGANELLE_PART	1.000	2_NUCLEAR_PART	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	
PSMD1	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	
PSMD3	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PANCREATIC_CANCER	1.000	
PSMD5	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	
PTBP1	1	
PTCH1	1	1_KEGG_HEDGEHOG_SIGNALING_PATHWAY	1.000	
PTEN	8	0_HALLMARK_G2M_CHECKPOINT	0.625	0_HALLMARK_E2F_TARGETS	0.625	1_KEGG_DNA_REPLICATION	0.625	1_KEGG_CELL_CYCLE	0.625	1_KEGG_PATHWAYS_IN_CANCER	0.625	1_KEGG_SMALL_CELL_LUNG_CANCER	0.625	2_REPLICATION_FORK	0.625	2_CHROMOSOMAL_PART	0.625	2_CHROMOSOME	0.625	2_DNA_METABOLIC_PROCESS	0.625	
PTHLH	1	
PTK2	6	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	0.833	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_COLORECTAL_CANCER	0.667	1_KEGG_PROSTATE_CANCER	0.667	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	0.667	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	
PTK2B	4	1_KEGG_PATHWAYS_IN_CANCER	1.000	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_DNA_REPLICATION	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.750	2_NUCLEUS	0.750	2_DNA_METABOLIC_PROCESS	0.750	2_BIOPOLYMER_METABOLIC_PROCESS	0.750	
PTK6	1	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_INFLAMMATORY_RESPONSE	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
PTPN1	1	
PTPN11	3	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_MYC_TARGETS_V1	0.667	1_KEGG_PYRIMIDINE_METABOLISM	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	0.667	
PTPN7	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_COMPLEMENT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	1.000	
PTPRA	1	2_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY	1.000	2_PHOSPHORIC_MONOESTER_HYDROLASE_ACTIVITY	1.000	2_PHOSPHORIC_ESTER_HYDROLASE_ACTIVITY	1.000	2_TRANSMEMBRANE_RECEPTOR_PROTEIN_PHOSPHATASE_ACTIVITY	1.000	2_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY	1.000	
PTPRF	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_ERBB_SIGNALING_PATHWAY	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	
PTPRM	1	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	
PTPRS	12	2_TRANSMEMBRANE_RECEPTOR_PROTEIN_PHOSPHATASE_ACTIVITY	0.833	2_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY	0.333	0_HALLMARK_E2F_TARGETS	0.167	1_KEGG_DNA_REPLICATION	0.167	1_KEGG_MISMATCH_REPAIR	0.167	1_KEGG_CELL_CYCLE	0.167	1_KEGG_PATHWAYS_IN_CANCER	0.167	2_NON_MEMBRANE_BOUND_ORGANELLE	0.167	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.167	2_CHROMOSOME	0.167	
PTRF	4	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	
PVRL3	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	
PWP1	2	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_IDENTICAL_PROTEIN_BINDING	1.000	0_HALLMARK_HYPOXIA	0.500	
PYGB	1	1_KEGG_INSULIN_SIGNALING_PATHWAY	1.000	
RAB27B	1	
RAB5A	1	
RAC1	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_RNA_POLYMERASE	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	
RAD17	1	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	2_REPLICATION_FORK	1.000	2_CHROMOSOMAL_PART	1.000	2_CHROMOSOME	1.000	2_DNA_METABOLIC_PROCESS	1.000	
RAD50	4	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_DNA_REPLICATION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_DNA_REPLICATION	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.750	2_CHROMOSOME	0.750	2_DNA_METABOLIC_PROCESS	0.750	
RAET1E	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_HEDGEHOG_SIGNALING	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	
RAF1	4	2_NUCLEUS	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_COLORECTAL_CANCER	0.500	1_KEGG_PROSTATE_CANCER	0.500	
RALGDS	1	
RAN	2	1_KEGG_CELL_CYCLE	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	2_NUCLEUS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_APOPTOSIS	0.500	
RANBP2	6	0_HALLMARK_G2M_CHECKPOINT	0.833	0_HALLMARK_E2F_TARGETS	0.833	1_KEGG_CELL_CYCLE	0.833	1_KEGG_PATHWAYS_IN_CANCER	0.833	0_HALLMARK_MYC_TARGETS_V1	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_PROSTATE_CANCER	0.667	2_ORGANELLE_PART	0.667	2_NUCLEAR_PART	0.667	2_NUCLEAR_LUMEN	0.667	
RAP2B	2	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ALLOGRAFT_REJECTION	0.500	1_KEGG_PYRIMIDINE_METABOLISM	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_BASE_EXCISION_REPAIR	0.500	
RARA	5	1_KEGG_FOCAL_ADHESION	0.800	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.800	0_HALLMARK_E2F_TARGETS	0.600	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.600	1_KEGG_CELL_CYCLE	0.600	1_KEGG_COLORECTAL_CANCER	0.600	2_NON_MEMBRANE_BOUND_ORGANELLE	0.600	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.600	2_SYSTEM_DEVELOPMENT	0.600	
RARB	1	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	1.000	
RARS	1	1_KEGG_AMINOACYL_TRNA_BIOSYNTHESIS	1.000	2_PORE_COMPLEX	1.000	2_CELL_FRACTION	1.000	2_NUCLEAR_PORE	1.000	2_NUCLEAR_MEMBRANE_PART	1.000	2_SOLUBLE_FRACTION	1.000	2_LIGASE_ACTIVITY_FORMING_CARBON_OXYGEN_BONDS	1.000	
RASA1	5	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	1_KEGG_CELL_CYCLE	0.600	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.600	1_KEGG_PROSTATE_CANCER	0.600	1_KEGG_MELANOMA	0.600	1_KEGG_SMALL_CELL_LUNG_CANCER	0.600	2_NUCLEUS	0.600	0_HALLMARK_G2M_CHECKPOINT	0.400	
RASGRF1	2	1_KEGG_MAPK_SIGNALING_PATHWAY	0.500	1_KEGG_CARDIAC_MUSCLE_CONTRACTION	0.500	1_KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM	0.500	1_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	0.500	1_KEGG_DILATED_CARDIOMYOPATHY	0.500	2_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX	0.500	2_CATION_CHANNEL_ACTIVITY	0.500	2_VOLTAGE_GATED_CHANNEL_ACTIVITY	0.500	2_GATED_CHANNEL_ACTIVITY	0.500	2_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY	0.500	
RASGRF2	2	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CARDIAC_MUSCLE_CONTRACTION	1.000	1_KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM	1.000	1_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	1.000	1_KEGG_DILATED_CARDIOMYOPATHY	1.000	2_CATION_CHANNEL_ACTIVITY	1.000	2_VOLTAGE_GATED_CHANNEL_ACTIVITY	1.000	2_GATED_CHANNEL_ACTIVITY	1.000	2_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY	1.000	2_VOLTAGE_GATED_CATION_CHANNEL_ACTIVITY	1.000	
RASGRP2	1	
RB1	3	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	2_NUCLEUS	1.000	2_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	1.000	2_REGULATION_OF_METABOLIC_PROCESS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.667	1_KEGG_COLORECTAL_CANCER	0.667	
RB1CC1	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_PYRIMIDINE_METABOLISM	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_COLORECTAL_CANCER	0.667	1_KEGG_PROSTATE_CANCER	0.667	
RBL2	3	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_MYC_TARGETS_V1	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_AXON_GUIDANCE	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	
RBM14	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	
RBMX	1	
RBMY1A1	48	2_NUCLEUS	0.333	1_KEGG_CELL_CYCLE	0.313	1_KEGG_PATHWAYS_IN_CANCER	0.292	0_HALLMARK_E2F_TARGETS	0.271	2_NUCLEAR_PART	0.271	2_NUCLEOLUS	0.271	1_KEGG_COLORECTAL_CANCER	0.250	1_KEGG_PROSTATE_CANCER	0.250	0_HALLMARK_G2M_CHECKPOINT	0.229	1_KEGG_ENDOMETRIAL_CANCER	0.229	
REL	1	
RELA	4	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_BIOPOLYMER_METABOLIC_PROCESS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.750	1_KEGG_DNA_REPLICATION	0.750	1_KEGG_MISMATCH_REPAIR	0.750	1_KEGG_APOPTOSIS	0.750	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_PROSTATE_CANCER	0.750	
RELN	16	1_KEGG_PATHWAYS_IN_CANCER	0.875	1_KEGG_COLORECTAL_CANCER	0.813	1_KEGG_PROSTATE_CANCER	0.813	0_HALLMARK_E2F_TARGETS	0.688	1_KEGG_CELL_CYCLE	0.688	1_KEGG_FOCAL_ADHESION	0.688	1_KEGG_ENDOMETRIAL_CANCER	0.688	2_NUCLEUS	0.688	2_DNA_METABOLIC_PROCESS	0.688	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	0.688	
RET	9	1_KEGG_PATHWAYS_IN_CANCER	1.000	0_HALLMARK_G2M_CHECKPOINT	0.778	0_HALLMARK_E2F_TARGETS	0.778	1_KEGG_CELL_CYCLE	0.778	2_CHROMOSOME	0.778	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.667	2_NUCLEAR_PART	0.667	2_NUCLEUS	0.667	
REV3L	4	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_COLORECTAL_CANCER	1.000	2_ORGANELLE_PART	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_NUCLEUS	1.000	
RFC1	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
RFC4	2	0_HALLMARK_DNA_REPAIR	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	2_REPLICATION_FORK	1.000	2_CHROMOSOMAL_PART	1.000	2_CHROMOSOME	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_DNA_REPLICATION	1.000	2_DNA_DEPENDENT_DNA_REPLICATION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	
RFX4	1	
RGL2	1	
RGMA	1	
RGMB	1	2_POSITIVE_REGULATION_OF_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1.000	2_POSITIVE_REGULATION_OF_TRANSCRIPTION	1.000	
RGS17	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PANCREATIC_CANCER	1.000	
RGS4	1	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	
RHOBTB1	2	
RHOBTB2	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	
RHOQ	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	
RHOT1	2	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	2_SYSTEM_DEVELOPMENT	1.000	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	1.000	
RHOT2	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	
RIF1	1	
RIMS2	6	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_PROSTATE_CANCER	0.500	2_NUCLEOLUS	0.500	2_BIOPOLYMER_METABOLIC_PROCESS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.333	1_KEGG_PYRIMIDINE_METABOLISM	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	
RING1	4	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_APOPTOSIS	0.500	1_KEGG_AXON_GUIDANCE	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.500	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	
RIPK1	4	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	2_NUCLEAR_PART	1.000	2_NUCLEUS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_COLORECTAL_CANCER	0.750	1_KEGG_ENDOMETRIAL_CANCER	0.750	2_NUCLEAR_LUMEN	0.750	
RIT2	1	
ROBO1	13	0_HALLMARK_G2M_CHECKPOINT	0.692	0_HALLMARK_E2F_TARGETS	0.692	1_KEGG_CELL_CYCLE	0.692	1_KEGG_PATHWAYS_IN_CANCER	0.692	2_DNA_METABOLIC_PROCESS	0.692	1_KEGG_DNA_REPLICATION	0.615	2_NON_MEMBRANE_BOUND_ORGANELLE	0.615	2_NUCLEUS	0.615	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.615	2_CHROMOSOME	0.615	
ROBO2	8	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.500	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_COLORECTAL_CANCER	0.500	1_KEGG_ENDOMETRIAL_CANCER	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_PROSTATE_CANCER	0.500	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.375	1_KEGG_APOPTOSIS	0.375	
ROBO3	11	1_KEGG_PATHWAYS_IN_CANCER	0.818	0_HALLMARK_E2F_TARGETS	0.636	1_KEGG_CELL_CYCLE	0.636	0_HALLMARK_G2M_CHECKPOINT	0.545	1_KEGG_FOCAL_ADHESION	0.545	1_KEGG_ECM_RECEPTOR_INTERACTION	0.545	2_NON_MEMBRANE_BOUND_ORGANELLE	0.545	2_NUCLEUS	0.545	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.545	2_CHROMOSOME	0.545	
ROBO4	1	
ROCK1	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	1.000	
ROS1	1	
RPA1	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_APOPTOSIS	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_BASE_EXCISION_REPAIR	0.667	1_KEGG_MISMATCH_REPAIR	0.667	1_KEGG_CELL_CYCLE	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_NUCLEUS	0.667	2_REPLICATION_FORK	0.667	
RPA2	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_FOCAL_ADHESION	1.000	
RPL11	1	
RPL14	3	
RPL18A	1	
RPL27A	1	
RPL5	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V2	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	
RPS6KA1	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_CHROMOSOMAL_PART	1.000	2_CHROMOSOME	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_BIOPOLYMER_METABOLIC_PROCESS	1.000	
RPS6KA2	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	
RPS6KA6	1	
RRAS	1	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	0_HALLMARK_KRAS_SIGNALING_UP	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_APOPTOSIS	1.000	
RRM1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	
RTN1	1	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	1.000	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	1.000	2_PHOSPHORIC_MONOESTER_HYDROLASE_ACTIVITY	1.000	2_HYDROLASE_ACTIVITY_ACTING_ON_ESTER_BONDS	1.000	2_PHOSPHORIC_ESTER_HYDROLASE_ACTIVITY	1.000	2_INOSITOL_OR_PHOSPHATIDYLINOSITOL_PHOSPHATASE_ACTIVITY	1.000	
RTN4	1	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	1.000	0_HALLMARK_P53_PATHWAY	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_THYROID_CANCER	1.000	2_NUCLEUS	1.000	
RUNX1T1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	
RXRA	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	1.000	1_KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	1.000	
RXRB	1	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	
RXRG	1	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_INTEGRIN_COMPLEX	1.000	
RYR1	12	1_KEGG_CELL_CYCLE	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	0_HALLMARK_E2F_TARGETS	0.417	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.417	2_NUCLEUS	0.417	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	1_KEGG_DNA_REPLICATION	0.333	
RYR2	44	1_KEGG_PATHWAYS_IN_CANCER	0.614	1_KEGG_CELL_CYCLE	0.523	1_KEGG_COLORECTAL_CANCER	0.477	2_NUCLEUS	0.477	0_HALLMARK_E2F_TARGETS	0.455	1_KEGG_PROSTATE_CANCER	0.455	1_KEGG_SMALL_CELL_LUNG_CANCER	0.455	2_BIOPOLYMER_METABOLIC_PROCESS	0.455	1_KEGG_ECM_RECEPTOR_INTERACTION	0.432	1_KEGG_P53_SIGNALING_PATHWAY	0.409	
RYR3	11	2_NUCLEUS	0.636	1_KEGG_CELL_CYCLE	0.545	1_KEGG_PATHWAYS_IN_CANCER	0.545	1_KEGG_COLORECTAL_CANCER	0.545	1_KEGG_PROSTATE_CANCER	0.545	2_CELL_PROLIFERATION_GO_0008283	0.545	0_HALLMARK_E2F_TARGETS	0.455	1_KEGG_P53_SIGNALING_PATHWAY	0.455	1_KEGG_ENDOMETRIAL_CANCER	0.455	1_KEGG_SMALL_CELL_LUNG_CANCER	0.455	
S1PR1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	
SBF1	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_OOCYTE_MEIOSIS	1.000	
SCG3	1	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	
SCN4A	3	
SCN5A	16	1_KEGG_PATHWAYS_IN_CANCER	0.375	2_NUCLEUS	0.375	0_HALLMARK_G2M_CHECKPOINT	0.313	0_HALLMARK_E2F_TARGETS	0.313	0_HALLMARK_MYC_TARGETS_V1	0.313	1_KEGG_CELL_CYCLE	0.313	1_KEGG_APOPTOSIS	0.313	1_KEGG_COLORECTAL_CANCER	0.313	1_KEGG_PROSTATE_CANCER	0.313	2_NUCLEOLUS	0.313	
SCN8A	2	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_WNT_SIGNALING_PATHWAY	0.500	1_KEGG_HEDGEHOG_SIGNALING_PATHWAY	0.500	
SCNN1B	3	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_INFLAMMATORY_RESPONSE	0.333	0_HALLMARK_IL2_STAT5_SIGNALING	0.333	1_KEGG_PYRIMIDINE_METABOLISM	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	0.333	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	
SCNN1D	4	2_SODIUM_CHANNEL_ACTIVITY	1.000	2_LIGAND_GATED_CHANNEL_ACTIVITY	0.500	
SCNN1G	2	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	1.000	2_EXCRETION	0.500	2_SODIUM_CHANNEL_ACTIVITY	0.500	
SDC2	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	
SDC3	1	
SELPLG	1	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	
SEMA6C	1	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY	1.000	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PANCREATIC_CANCER	1.000	
SET	1	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	1.000	
SF1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	1.000	
SF3B1	2	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_OOCYTE_MEIOSIS	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	
SF3B3	1	2_SMALL_NUCLEAR_RIBONUCLEOPROTEIN_COMPLEX	1.000	
SFN	1	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
SFTPB	1	
SGK1	1	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	1.000	
SH2D3C	2	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	
SH3BP5	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_THYROID_CANCER	1.000	2_NUCLEOPLASM	1.000	2_ORGANELLE_PART	1.000	
SHC1	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_MYC_TARGETS_V1	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_MISMATCH_REPAIR	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_COLORECTAL_CANCER	0.667	2_ORGANELLE_PART	0.667	2_NUCLEAR_PART	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	
SHH	1	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
SIN3A	6	1_KEGG_PATHWAYS_IN_CANCER	0.833	1_KEGG_CELL_CYCLE	0.667	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	0.667	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PROSTATE_CANCER	0.500	1_KEGG_THYROID_CANCER	0.500	2_NUCLEAR_PART	0.500	
SIN3B	2	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_SYSTEM_DEVELOPMENT	1.000	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	1.000	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	1.000	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	0.500	0_HALLMARK_TGF_BETA_SIGNALING	0.500	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	
SIRT2	1	0_HALLMARK_TGF_BETA_SIGNALING	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	2_NEGATIVE_REGULATION_OF_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1.000	2_NEGATIVE_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	1.000	2_REGULATION_OF_DNA_BINDING	1.000	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1.000	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	1.000	2_REGULATION_OF_TRANSCRIPTION_FACTOR_ACTIVITY	1.000	2_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	1.000	2_REGULATION_OF_GENE_EXPRESSION	1.000	
SLA	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	2_NUCLEOPLASM	1.000	
SLC12A2	2	1_KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	0.500	1_KEGG_VIBRIO_CHOLERAE_INFECTION	0.500	
SLC25A5	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_IL2_STAT5_SIGNALING	0.500	1_KEGG_PROTEASOME	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_COLORECTAL_CANCER	0.500	1_KEGG_PANCREATIC_CANCER	0.500	
SLC2A4	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	
SLIT1	8	1_KEGG_AXON_GUIDANCE	0.500	2_AXON_GUIDANCE	0.375	0_HALLMARK_G2M_CHECKPOINT	0.125	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.125	1_KEGG_MAPK_SIGNALING_PATHWAY	0.125	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	0.125	1_KEGG_CHEMOKINE_SIGNALING_PATHWAY	0.125	1_KEGG_APOPTOSIS	0.125	1_KEGG_FOCAL_ADHESION	0.125	1_KEGG_ECM_RECEPTOR_INTERACTION	0.125	
SLIT2	2	
SLIT3	3	
SMAD1	4	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	2_NUCLEUS	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_BIOPOLYMER_METABOLIC_PROCESS	1.000	2_DNA_REPLICATION	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.750	
SMAD2	4	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	
SMAD3	8	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	1.000	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	1.000	1_KEGG_CELL_CYCLE	0.750	1_KEGG_PATHWAYS_IN_CANCER	0.750	1_KEGG_COLORECTAL_CANCER	0.750	1_KEGG_PROSTATE_CANCER	0.750	0_HALLMARK_G2M_CHECKPOINT	0.625	0_HALLMARK_E2F_TARGETS	0.625	0_HALLMARK_MYC_TARGETS_V1	0.625	1_KEGG_DNA_REPLICATION	0.625	
SMAD4	25	1_KEGG_PATHWAYS_IN_CANCER	0.880	1_KEGG_CELL_CYCLE	0.800	1_KEGG_COLORECTAL_CANCER	0.720	2_NUCLEUS	0.600	2_CELL_PROLIFERATION_GO_0008283	0.600	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	0.600	0_HALLMARK_E2F_TARGETS	0.560	1_KEGG_SMALL_CELL_LUNG_CANCER	0.560	2_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	0.560	2_REGULATION_OF_METABOLIC_PROCESS	0.560	
SMAD9	5	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_P53_SIGNALING_PATHWAY	0.800	1_KEGG_COLORECTAL_CANCER	0.800	1_KEGG_ENDOMETRIAL_CANCER	0.800	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	0.800	0_HALLMARK_E2F_TARGETS	0.600	1_KEGG_CELL_CYCLE	0.600	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	0.600	
SMARCA1	1	
SMARCA2	6	1_KEGG_PATHWAYS_IN_CANCER	0.833	1_KEGG_CELL_CYCLE	0.667	1_KEGG_COLORECTAL_CANCER	0.667	2_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	0.667	2_REGULATION_OF_METABOLIC_PROCESS	0.667	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_ENDOMETRIAL_CANCER	0.500	1_KEGG_PROSTATE_CANCER	0.500	2_NUCLEAR_LUMEN	0.500	2_NUCLEUS	0.500	
SMARCA4	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_COLORECTAL_CANCER	0.667	2_NUCLEUS	0.667	2_DNA_METABOLIC_PROCESS	0.667	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.667	2_DNA_REPLICATION	0.667	
SMARCC2	1	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_ESTROGEN_RESPONSE_LATE	1.000	0_HALLMARK_P53_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	
SMARCD2	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	1.000	1_KEGG_CHEMOKINE_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	
SMARCE1	1	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	
SMC2	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_REPLICATION_FORK	1.000	2_CHROMOSOMAL_PART	1.000	2_CHROMOSOME	1.000	
SMC4	1	
SMG5	3	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	2_ORGANELLE_PART	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_NUCLEUS	1.000	2_REPLICATION_FORK	1.000	
SMO	1	
SMPD1	3	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_COLORECTAL_CANCER	0.667	1_KEGG_ENDOMETRIAL_CANCER	0.667	1_KEGG_PROSTATE_CANCER	0.667	
SMPD2	2	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_NUCLEUS	1.000	2_SIGNAL_TRANSDUCTION	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	1.000	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	1.000	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	
SNRPB2	1	2_SMALL_NUCLEAR_RIBONUCLEOPROTEIN_COMPLEX	1.000	2_SPLICEOSOME	1.000	
SNTA1	2	
SNTB2	1	2_BASAL_LAMINA	1.000	2_DYSTROPHIN_ASSOCIATED_GLYCOPROTEIN_COMPLEX	1.000	
SOCS3	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	2_NUCLEUS	1.000	2_CHROMOSOMAL_PART	1.000	
SOCS4	2	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_SYSTEM_DEVELOPMENT	1.000	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	1.000	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	1.000	2_ORGAN_DEVELOPMENT	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	
SORBS3	1	
SOS1	5	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_GLIOMA	0.800	1_KEGG_PROSTATE_CANCER	0.800	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.600	1_KEGG_WNT_SIGNALING_PATHWAY	0.600	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.600	1_KEGG_PATHWAYS_IN_CANCER	0.600	1_KEGG_COLORECTAL_CANCER	0.600	1_KEGG_ENDOMETRIAL_CANCER	0.600	
SOX9	5	
SP100	1	
SP2	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	
SP3	3	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_MYC_TARGETS_V1	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.667	
SPEN	4	
SPHK1	3	0_HALLMARK_DNA_REPAIR	0.667	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_MYC_TARGETS_V1	0.667	1_KEGG_PURINE_METABOLISM	0.667	1_KEGG_PYRIMIDINE_METABOLISM	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_MISMATCH_REPAIR	0.667	1_KEGG_CELL_CYCLE	0.667	2_NUCLEOPLASM	0.667	
SPHK2	1	
SPI1	2	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	
SPIB	2	
SPOCK3	2	
SPTA1	20	2_CELL_CORTEX_PART	0.900	2_CELL_CORTEX	0.900	2_CORTICAL_CYTOSKELETON	0.900	2_CORTICAL_ACTIN_CYTOSKELETON	0.900	2_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON	0.900	1_KEGG_MAPK_SIGNALING_PATHWAY	0.050	1_KEGG_ERBB_SIGNALING_PATHWAY	0.050	1_KEGG_CELL_CYCLE	0.050	1_KEGG_P53_SIGNALING_PATHWAY	0.050	1_KEGG_APOPTOSIS	0.050	
SPTAN1	5	2_CELL_CORTEX_PART	1.000	2_CELL_CORTEX	1.000	2_CORTICAL_CYTOSKELETON	1.000	2_CORTICAL_ACTIN_CYTOSKELETON	1.000	2_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON	1.000	
SPTBN2	1	
SRC	1	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PANCREATIC_CANCER	1.000	1_KEGG_BLADDER_CANCER	1.000	
SRCAP	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_PROTEASOME	0.500	1_KEGG_MAPK_SIGNALING_PATHWAY	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_OOCYTE_MEIOSIS	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_APOPTOSIS	0.500	1_KEGG_WNT_SIGNALING_PATHWAY	0.500	
SREBF1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_NON_HOMOLOGOUS_END_JOINING	1.000	1_KEGG_CELL_CYCLE	1.000	
SRMS	2	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	0_HALLMARK_HYPOXIA	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_P53_PATHWAY	0.500	1_KEGG_MAPK_SIGNALING_PATHWAY	0.500	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_APOPTOSIS	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	
SRPK1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_OOCYTE_MEIOSIS	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	
SRPX	2	
SSTR4	1	
ST8SIA4	1	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	1.000	0_HALLMARK_INFLAMMATORY_RESPONSE	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	1.000	1_KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	1.000	
STAB1	6	2_RECEPTOR_MEDIATED_ENDOCYTOSIS	0.667	0_HALLMARK_G2M_CHECKPOINT	0.167	0_HALLMARK_MTORC1_SIGNALING	0.167	0_HALLMARK_E2F_TARGETS	0.167	0_HALLMARK_MYC_TARGETS_V1	0.167	1_KEGG_PYRIMIDINE_METABOLISM	0.167	1_KEGG_DNA_REPLICATION	0.167	1_KEGG_PROTEASOME	0.167	1_KEGG_BASE_EXCISION_REPAIR	0.167	1_KEGG_CELL_CYCLE	0.167	
STAG2	1	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PANCREATIC_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	
STAT3	4	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.750	2_NUCLEUS	0.750	2_BIOPOLYMER_METABOLIC_PROCESS	0.750	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.750	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	
STAT4	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	
STAT5A	7	1_KEGG_FOCAL_ADHESION	0.857	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.714	1_KEGG_ECM_RECEPTOR_INTERACTION	0.714	1_KEGG_PATHWAYS_IN_CANCER	0.714	0_HALLMARK_G2M_CHECKPOINT	0.571	0_HALLMARK_E2F_TARGETS	0.571	1_KEGG_DNA_REPLICATION	0.571	1_KEGG_COLORECTAL_CANCER	0.571	1_KEGG_PROSTATE_CANCER	0.571	1_KEGG_ACUTE_MYELOID_LEUKEMIA	0.571	
STAT5B	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	2_NUCLEUS	1.000	
STK4	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	2_NUCLEOPLASM	1.000	2_ORGANELLE_PART	1.000	2_NUCLEAR_CHROMOSOME	1.000	
SUPT16H	5	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_E2F_TARGETS	0.800	1_KEGG_DNA_REPLICATION	0.800	2_NUCLEUS	0.800	2_DNA_METABOLIC_PROCESS	0.800	2_DNA_REPLICATION	0.800	0_HALLMARK_MYC_TARGETS_V1	0.600	1_KEGG_CELL_CYCLE	0.600	1_KEGG_FOCAL_ADHESION	0.600	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	
SUPT5H	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_AXON_GUIDANCE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	
SV2B	1	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	
SVEP1	6	
TAF1A	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_RNA_POLYMERASE	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	
TAF1B	1	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_ERBB_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	
TAF1C	1	2_NUCLEOPLASM	1.000	2_NUCLEAR_PART	1.000	2_ORGANELLE_LUMEN	1.000	2_NUCLEAR_LUMEN	1.000	2_DNA_DIRECTED_RNA_POLYMERASE_COMPLEX	1.000	2_NUCLEUS	1.000	2_DNA_DIRECTED_RNA_POLYMERASEII_CORE_COMPLEX	1.000	2_MEMBRANE_ENCLOSED_LUMEN	1.000	2_RNA_POLYMERASE_COMPLEX	1.000	2_NUCLEAR_DNA_DIRECTED_RNA_POLYMERASE_COMPLEX	1.000	
TAF1L	1	2_N_ACETYLTRANSFERASE_ACTIVITY	1.000	2_HISTONE_ACETYLTRANSFERASE_ACTIVITY	1.000	2_N_ACYLTRANSFERASE_ACTIVITY	1.000	2_ACETYLTRANSFERASE_ACTIVITY	1.000	2_TRANSFERASE_ACTIVITY_TRANSFERRING_GROUPS_OTHER_THAN_AMINO_ACYL_GROUPS	1.000	
TAF4	1	
TAOK3	1	
TARBP2	1	2_DOUBLE_STRANDED_RNA_BINDING	1.000	
TBL1Y	6	1_KEGG_WNT_SIGNALING_PATHWAY	0.667	1_KEGG_COLORECTAL_CANCER	0.500	1_KEGG_ENDOMETRIAL_CANCER	0.500	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_PROSTATE_CANCER	0.333	1_KEGG_BASAL_CELL_CARCINOMA	0.333	1_KEGG_MELANOMA	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.167	
TBP	34	1_KEGG_PATHWAYS_IN_CANCER	0.912	1_KEGG_COLORECTAL_CANCER	0.853	1_KEGG_PROSTATE_CANCER	0.794	1_KEGG_ENDOMETRIAL_CANCER	0.706	2_NUCLEUS	0.676	1_KEGG_CELL_CYCLE	0.647	2_NUCLEOLUS	0.647	1_KEGG_FOCAL_ADHESION	0.618	1_KEGG_P53_SIGNALING_PATHWAY	0.588	1_KEGG_SMALL_CELL_LUNG_CANCER	0.588	
TBX5	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_UV_RESPONSE_DN	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_MELANOMA	0.667	2_SYSTEM_DEVELOPMENT	0.667	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.667	2_CELL_PROLIFERATION_GO_0008283	0.667	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	0.667	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	0.667	
TBXAS1	1	
TCF12	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	2_NUCLEAR_PART	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_NUCLEUS	0.667	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.667	
TCF3	3	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_DNA_REPLICATION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_MYC_TARGETS_V1	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	2_NUCLEAR_PART	0.667	
TCF4	2	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_PROSTATE_CANCER	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_MTORC1_SIGNALING	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	
TCF7	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_GLIOMA	1.000	
TCF7L2	15	1_KEGG_PATHWAYS_IN_CANCER	0.933	1_KEGG_ENDOMETRIAL_CANCER	0.733	2_NUCLEUS	0.733	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_COLORECTAL_CANCER	0.667	1_KEGG_FOCAL_ADHESION	0.600	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.600	1_KEGG_PROSTATE_CANCER	0.600	2_NUCLEAR_LUMEN	0.600	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	0.600	
TCHH	10	
TEK	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.667	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	0.667	
TEP1	1	
TFAP2A	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	
TFAP2B	2	1_KEGG_APOPTOSIS	1.000	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_IL2_STAT5_SIGNALING	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_AXON_GUIDANCE	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	
TFAP2C	2	
TFDP1	2	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	2_NUCLEAR_PART	1.000	2_ORGANELLE_LUMEN	1.000	2_NUCLEAR_LUMEN	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	
TGFB1	1	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	2_ORGAN_MORPHOGENESIS	1.000	
TGFBR1	6	1_KEGG_CELL_CYCLE	0.833	1_KEGG_COLORECTAL_CANCER	0.833	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	2_NUCLEUS	0.667	2_DNA_METABOLIC_PROCESS	0.667	2_DNA_REPLICATION	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.500	
TGFBR2	6	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_FOCAL_ADHESION	0.833	1_KEGG_ECM_RECEPTOR_INTERACTION	0.833	1_KEGG_COLORECTAL_CANCER	0.833	1_KEGG_PROSTATE_CANCER	0.833	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.667	1_KEGG_ENDOMETRIAL_CANCER	0.667	1_KEGG_GLIOMA	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	2_SYSTEM_DEVELOPMENT	0.667	
TGIF1	10	1_KEGG_PATHWAYS_IN_CANCER	0.300	1_KEGG_P53_SIGNALING_PATHWAY	0.200	1_KEGG_ENDOMETRIAL_CANCER	0.200	1_KEGG_THYROID_CANCER	0.200	2_TRANSCRIPTION_DNA_DEPENDENT	0.200	2_RNA_BIOSYNTHETIC_PROCESS	0.200	2_TRANSCRIPTION	0.200	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	0.100	0_HALLMARK_G2M_CHECKPOINT	0.100	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	0.100	
TGM1	1	
THBS2	9	2_NUCLEUS	0.778	2_CELL_PROLIFERATION_GO_0008283	0.778	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	2_BIOPOLYMER_METABOLIC_PROCESS	0.667	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.667	0_HALLMARK_G2M_CHECKPOINT	0.556	1_KEGG_DNA_REPLICATION	0.556	
THBS4	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_COMPLEMENT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	1.000	
THRA	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	
THRB	1	
TIAM1	2	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_THYROID_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V2	0.500	
TJP1	1	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_INFLAMMATORY_RESPONSE	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
TJP2	8	2_CALCIUM_INDEPENDENT_CELL_CELL_ADHESION	0.750	1_KEGG_TIGHT_JUNCTION	0.625	2_CELL_JUNCTION	0.625	2_INTERCELLULAR_JUNCTION	0.625	2_IDENTICAL_PROTEIN_BINDING	0.375	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_E2F_TARGETS	0.250	0_HALLMARK_MYC_TARGETS_V1	0.250	1_KEGG_DNA_REPLICATION	0.250	1_KEGG_CELL_CYCLE	0.250	
TJP3	2	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_TIGHT_JUNCTION	1.000	2_CELL_JUNCTION	1.000	2_TIGHT_JUNCTION	1.000	2_INTERCELLULAR_JUNCTION	1.000	2_APICAL_JUNCTION_COMPLEX	1.000	2_APICOLATERAL_PLASMA_MEMBRANE	1.000	2_CALCIUM_INDEPENDENT_CELL_CELL_ADHESION	1.000	2_CELL_CELL_ADHESION	1.000	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	0.500	
TLE1	3	0_HALLMARK_G2M_CHECKPOINT	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	2_ORGANELLE_LUMEN	0.667	2_NUCLEAR_LUMEN	0.667	2_MEMBRANE_ENCLOSED_LUMEN	0.667	2_NUCLEOLUS	0.667	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	0.667	
TLL2	3	
TLN1	10	1_KEGG_PATHWAYS_IN_CANCER	0.900	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_E2F_TARGETS	0.800	1_KEGG_DNA_REPLICATION	0.800	1_KEGG_CELL_CYCLE	0.800	1_KEGG_FOCAL_ADHESION	0.800	2_CHROMOSOME	0.800	1_KEGG_ECM_RECEPTOR_INTERACTION	0.700	1_KEGG_SMALL_CELL_LUNG_CANCER	0.700	2_NON_MEMBRANE_BOUND_ORGANELLE	0.700	
TLR4	1	
TLR7	1	1_KEGG_APOPTOSIS	1.000	
TLR9	2	2_REGULATION_OF_INTERFERON_GAMMA_BIOSYNTHETIC_PROCESS	0.500	2_INTERFERON_GAMMA_BIOSYNTHETIC_PROCESS	0.500	
TNC	8	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	0.875	1_KEGG_PATHWAYS_IN_CANCER	0.750	0_HALLMARK_E2F_TARGETS	0.625	1_KEGG_CELL_CYCLE	0.625	1_KEGG_COLORECTAL_CANCER	0.625	1_KEGG_PROSTATE_CANCER	0.625	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_DNA_REPLICATION	0.500	
TNF	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	
TNFAIP6	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	1.000	
TNFRSF10A	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_ORGANELLE_PART	1.000	2_NUCLEAR_PART	1.000	2_ORGANELLE_LUMEN	1.000	
TNFRSF13B	1	
TNFRSF1A	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	
TNIK	1	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_P53_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	
TNKS	4	
TNN	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_IL2_STAT5_SIGNALING	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PANCREATIC_CANCER	1.000	
TNPO2	1	
TNR	3	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_COLORECTAL_CANCER	0.667	1_KEGG_ENDOMETRIAL_CANCER	0.667	1_KEGG_GLIOMA	0.667	1_KEGG_PROSTATE_CANCER	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	0.333	
TNXB	18	1_KEGG_FOCAL_ADHESION	0.111	1_KEGG_PATHWAYS_IN_CANCER	0.111	1_KEGG_COLORECTAL_CANCER	0.111	1_KEGG_ENDOMETRIAL_CANCER	0.111	1_KEGG_PROSTATE_CANCER	0.111	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.111	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	0.056	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.056	0_HALLMARK_G2M_CHECKPOINT	0.056	0_HALLMARK_E2F_TARGETS	0.056	
TOP1	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	0.667	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.667	1_KEGG_COLORECTAL_CANCER	0.667	1_KEGG_ENDOMETRIAL_CANCER	0.667	
TOP2A	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_ORGANELLE_PART	1.000	
TP53	108	1_KEGG_P53_SIGNALING_PATHWAY	0.907	1_KEGG_PATHWAYS_IN_CANCER	0.880	1_KEGG_COLORECTAL_CANCER	0.787	1_KEGG_CELL_CYCLE	0.759	1_KEGG_PROSTATE_CANCER	0.750	2_NUCLEUS	0.750	1_KEGG_ENDOMETRIAL_CANCER	0.704	2_CELL_PROLIFERATION_GO_0008283	0.694	0_HALLMARK_E2F_TARGETS	0.685	2_NUCLEOLUS	0.620	
TP53BP1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_HEDGEHOG_SIGNALING	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	
TRADD	1	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_NUCLEUS	1.000	2_SYSTEM_DEVELOPMENT	1.000	
TRAF1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
TRAF2	2	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	1.000	2_RESPONSE_TO_STRESS	1.000	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	1.000	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	
TRAF5	2	
TRAP1	1	
TRIM22	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_ORGANELLE_PART	1.000	
TRIM71	3	
TRIO	1	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_GNRH_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	1_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	1.000	1_KEGG_DILATED_CARDIOMYOPATHY	1.000	
TRPC3	3	
TRPC4	6	1_KEGG_PATHWAYS_IN_CANCER	0.833	1_KEGG_CELL_CYCLE	0.667	1_KEGG_COLORECTAL_CANCER	0.667	1_KEGG_PANCREATIC_CANCER	0.667	1_KEGG_ENDOMETRIAL_CANCER	0.667	1_KEGG_PROSTATE_CANCER	0.667	1_KEGG_MELANOMA	0.667	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	0.667	2_NUCLEUS	0.667	0_HALLMARK_G2M_CHECKPOINT	0.500	
TRPC6	7	1_KEGG_P53_SIGNALING_PATHWAY	0.714	0_HALLMARK_E2F_TARGETS	0.571	2_NUCLEUS	0.571	0_HALLMARK_G2M_CHECKPOINT	0.429	1_KEGG_DNA_REPLICATION	0.429	1_KEGG_MISMATCH_REPAIR	0.429	1_KEGG_CELL_CYCLE	0.429	1_KEGG_FOCAL_ADHESION	0.429	1_KEGG_PATHWAYS_IN_CANCER	0.429	2_NUCLEAR_LUMEN	0.429	
TRPV4	2	
TRPV5	2	
TSC2	1	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_THYROID_CANCER	1.000	
TSSK1B	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_PROTEASOME	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	1.000	
TTF1	1	
TTN	62	1_KEGG_PATHWAYS_IN_CANCER	0.387	2_SARCOMERE	0.323	2_MYOFIBRIL	0.323	2_CONTRACTILE_FIBER_PART	0.323	2_CONTRACTILE_FIBER	0.290	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	0.290	1_KEGG_COLORECTAL_CANCER	0.274	1_KEGG_CELL_CYCLE	0.258	1_KEGG_ENDOMETRIAL_CANCER	0.258	2_NUCLEUS	0.258	
TUBA3C	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_COLORECTAL_CANCER	0.500	2_NUCLEUS	0.500	
TUBB1	1	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
TUBB2A	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	
TULP2	1	
TYK2	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_ORGANELLE_PART	1.000	2_NUCLEAR_PART	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_NUCLEUS	1.000	
UBE2E1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_ERBB_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	1.000	
UBE3A	1	0_HALLMARK_MYC_TARGETS_V2	1.000	2_NUCLEAR_PART	1.000	2_ORGANELLE_LUMEN	1.000	2_NUCLEAR_LUMEN	1.000	2_NUCLEUS	1.000	2_MEMBRANE_ENCLOSED_LUMEN	1.000	2_NUCLEOLUS	1.000	
UBTF	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	
ULK1	1	
UNC5A	1	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PURINE_METABOLISM	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	
UNC5C	1	1_KEGG_AXON_GUIDANCE	1.000	2_AXON_GUIDANCE	1.000	
UNC5D	3	1_KEGG_AXON_GUIDANCE	0.667	
UPF1	1	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	
USP14	2	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_MYC_TARGETS_V2	0.500	1_KEGG_PURINE_METABOLISM	0.500	1_KEGG_PYRIMIDINE_METABOLISM	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_CELL_CYCLE	0.500	
USP9X	1	
UTRN	10	1_KEGG_FOCAL_ADHESION	0.600	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	2_NUCLEUS	0.500	2_DNA_METABOLIC_PROCESS	0.500	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.500	1_KEGG_DNA_REPLICATION	0.400	
VARS	1	
VAV1	3	1_KEGG_FOCAL_ADHESION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_COLORECTAL_CANCER	0.667	1_KEGG_ENDOMETRIAL_CANCER	0.667	1_KEGG_PROSTATE_CANCER	0.667	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.667	2_ORGAN_DEVELOPMENT	0.667	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.333	
VAV2	2	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	1.000	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	1.000	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_MYC_TARGETS_V2	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_PYRIMIDINE_METABOLISM	0.500	
VCAM1	3	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_MELANOMA	1.000	2_NUCLEUS	1.000	2_CELL_DEVELOPMENT	1.000	2_PROGRAMMED_CELL_DEATH	1.000	
VCAN	15	1_KEGG_PATHWAYS_IN_CANCER	0.933	1_KEGG_CELL_CYCLE	0.733	1_KEGG_COLORECTAL_CANCER	0.733	1_KEGG_PROSTATE_CANCER	0.733	0_HALLMARK_G2M_CHECKPOINT	0.667	1_KEGG_FOCAL_ADHESION	0.667	2_NUCLEUS	0.667	0_HALLMARK_E2F_TARGETS	0.600	2_DNA_METABOLIC_PROCESS	0.600	1_KEGG_P53_SIGNALING_PATHWAY	0.533	
VDAC1	1	2_PORE_COMPLEX	1.000	
VIPR2	3	
VLDLR	1	0_HALLMARK_MYOGENESIS	1.000	1_KEGG_MAPK_SIGNALING_PATHWAY	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_PANCREATIC_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	
VTN	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	
WDR3	1	
WHSC2	1	
WISP1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	
WNK1	5	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	0.800	1_KEGG_OOCYTE_MEIOSIS	0.600	1_KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	0.600	1_KEGG_GAP_JUNCTION	0.600	1_KEGG_GNRH_SIGNALING_PATHWAY	0.600	1_KEGG_MELANOGENESIS	0.600	1_KEGG_VIBRIO_CHOLERAE_INFECTION	0.600	1_KEGG_DILATED_CARDIOMYOPATHY	0.600	0_HALLMARK_G2M_CHECKPOINT	0.400	0_HALLMARK_E2F_TARGETS	0.400	
WNT3A	1	1_KEGG_HEDGEHOG_SIGNALING_PATHWAY	1.000	
WT1	2	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_WNT_SIGNALING_PATHWAY	0.500	1_KEGG_HEDGEHOG_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	0.500	
WWP1	5	
XIAP	2	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_BASE_EXCISION_REPAIR	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_APOPTOSIS	0.500	
XPO1	2	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_ERBB_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_THYROID_CANCER	1.000	
XPO5	1	
XRCC1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	
XRCC3	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_BASE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	
YWHAH	1	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_APOPTOSIS	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_COLORECTAL_CANCER	1.000	
ZAP70	4	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	1_KEGG_PATHWAYS_IN_CANCER	0.750	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	0.750	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_APOPTOSIS	0.500	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	0.500	1_KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.500	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.500	
ZNF408	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	0.500	0_HALLMARK_MTORC1_SIGNALING	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_PROTEASOME	0.500	1_KEGG_BASE_EXCISION_REPAIR	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_FOCAL_ADHESION	0.500	
ZYX	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_MYC_TARGETS_V2	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_PYRIMIDINE_METABOLISM	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	
